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ABSTRACT: The synthesis of linear- and (1→6)-branched β-(1→3)-D-galactans, structures found in plant arabinogalactan 
proteins (AGPs) is described. The synthetic strategy relies on iterative couplings of mono- and disaccharide thioglycoside 
donors, followed by a late stage glycosylation of heptagalactan backbone acceptors to introduce branching. A key finding from 
the synthetic study was the need to match protective groups in order to tune reactivity and ensure selectivity during the assem-
bly. Carbohydrate microarrays were generated to enable the detailed epitope mapping of two monoclonal antibodies known to 
recognize AGPs: JIM16 and JIM133. 
Introduction. 
Arabinogalactan protein (AGP) is a widely occurring proteoglycan 
in plants, associated with the plasma membrane and the cell wall. 
AGP is one of the most complex families of macromolecules found 
in plants, due to a great diversity of glycans decorating the protein 
backbone and constituting 90-98% of the total mass.1 Although this 
complexity has made it impossible to address the precise function 
of individual AGPs, they are known to be involved in several pro-
cesses in plant growth and development including differentiation,2 
signaling,3 root growth,4 embryogenesis5 and programmed cell 
death.6 Characterization of the glycan structures of AGPs is 
complicated by difficulties in the isolation of single molecules 
and the micro-heterogeneity found in the constituent chains. 
Knowledge of the glycan structure is based on NMR characteriza-
tion of oligosaccharide fragments or binding of monoclonal anti-
bodies to specific carbohydrate epitopes.7 AGP glycans are pre-
dominantly type II arabinogalactan chains of 30-120 monosaccha-
ride residues that are O-glycosidically linked to hydroxyproline 
(Hyp) residues in the protein backbone.8 The type II AGs have a 
β-(1→3)-linked D-galactopyranosyl (D-Galp) backbone substituted 
at C-6 with side-chains of β-(1→6)-linked galactose. The side 
chains contain a great diversity of monosaccharides including 
arabinofuranose, rhamnose, fucose and glucuronic acid. The AGs 
are generally neutral albeit some GlcpA-rich versions have been 
found in gum arabic.9 
Knowledge of the AGP glycan backbone’s biological functions is 
very limited. Since well-defined oligosaccharides have proven to 
be useful tools for elucidating protein-carbohydrate interactions 
(e.g. as enzyme substrates10 and for mapping the epitopes of mon-
oclonal antibodies11,12), we set out to synthesize a range of linear 
and branched β-(1→3)-linked galactans (Figure 1).13 Since the 
AGP structure is immensely complex, there are an almost unlim-
ited number of substructures which could be targeted for synthe-
sis. The criteria used for selecting the structures were the follow-
ing: 1) both linear and branched AGP motifs should be repre-
sented; 2) branching should occur at two different positions on 
the backbone; 3) the side-chains should contain both arabinose 
and galactose; 4) both types of galactan branching (β-(1→3)- and 
β-(1→6)-linked) should be represented. A final consideration was 
to ensure the structures targeted (1–7) were complimentary to the 
AGP previously prepared by Pfrengle and co-workers.13    
We aimed to prepare a central building block 10, which could be 
converted to a disaccharide donor 15. This would lower the num-
ber of critical glycosylation reactions during the assembly of the 
 larger oligosaccharides. Fenger & Madsen showed that it is pos-
sible to glycosylate the 3-position of galactose even though the 2-
position is unprotected, but it was necessary to protect the 2-po-
sition after every glycosylation.14 To circumvent this, we decided 
to protect the 2-, 4- and 6-positions permanently and use tempo-
rary protection of the 3-position. A pivaloyl group was chosen for 
the 2-position since neighboring group participation was required 
to ensure β-selectivity. The pivaloyl group furthermore has the 
advantage over acetyl groups that it reduces the risk of orthoester 
formation, which had been a problem in the galactan synthesis by 
Kováč.15 However, McGill and Williams observed lower yields 
using a pivalyl-protected donor.16 Especially the detection of an 
α-anomer and transesterification products during their reaction 
conditions indicate orthoester formation. Nevertheless, we de-
cided to use the pivaloyl group in the 2-position. The 4- and 6-
positions were protected with a benzylidene acetal, which is eas-
ily introduced and is sterically undemanding. At first an acetyl 
group was chosen for temporary protection of the 3-position, as 
its selective removal in the presence of the more bulky pivaloyl 
esters has been described.17 Scheme 1 shows the building blocks 
required to assemble the backbone.  
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Figure 1. Target structures (1–7). 
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Scheme 1. Building blocks for galactan synthesis  
 
Results and Discussion. 
Starting from the known diol 818 regioselective acetylation via 
formation of the stannylene acetal with Bu2SnO was performed, 
followed by treatment with AcCl and 4Å molecular sieves 
(Scheme 1).19 Treatment of 9a with PivCl, Et3N and DMAP af-
forded the fully protected thioglycoside 10a in 88% yield. In or-
der to prepare N-phenyltrifluoroacetimidate (PTFAI) donor 12a, 
the thioglycoside had to be hydrolyzed. This turned out to be chal-
lenging due to migration of the pivaloyl group and partial hydrol-
ysis of the benzylidene acetal. After screening several reported 
conditions20,21, the use of weak bases and NBS in H2O/MeCN af-
forded 11a in 75% (pyridine) and 84% yield (2,6-lutidine).  
The selective deacetylation to give acceptor 14 turned out to be 
just as challenging. It was expected that the acetyl group could be 
removed using Zemplén conditions without affecting the pivaloyl 
group as shown by Andersen et al.18 However, this resulted in 
extensive migration as well as deprotection of the pivaloyl ester. 
Most likely, the pivaloyl group first migrates to the 3-position, 
where it is more easily accessible and is therefore subjected to 
transesterification. Decreasing both NaOMe concentration and 
temperature improved the yield to 59%. Xu et al. had reported 
that Mg(OMe)2 can be used as a milder alternative to NaOMe.22 
 In our case, no deprotection of the pivaloyl was observed but mi-
gration persisted. The same was true for the even milder condi-
tions using ammonia in methanol.23 Alternatively, reductive re-
moval of the acetate was attempted. DIBAL-H did not give rise 
to migration but deprotection of the Piv group was observed. Sim-
ilar cases had been reported by Nicolaou and co-workers.24 Grat-
ifyingly, the more bulky reducing agents LiEt3BH (superhydride) 
and Li(sec-Bu)3BH (L-selectride) provided product 14 in an ex-
cellent yield of 94%.25 
With access to both donor 12a and acceptor 14, the disaccharide 
donor 15a was prepared in 92% yield by a TMSOTf-mediated gly-
cosylation (Scheme 1). The disaccharide 15a was converted to ac-
ceptor 16 in two steps. NIS/TESOTf-promoted glycosylation of 
benzyl alcohol with disaccharide 15a gave the β-benzyl glycoside 
in 75% yield and subsequent deacetylation with superhydride af-
forded 16 in 90% yield.  
In order to access branched galactans, we envisioned to use a mon-
osaccharide donor with a temporary C6-O protecting group and in-
troduce this building block at either the third or fifth sugar of a 
backbone heptasaccharide. Starting from thioglycoside 10a, build-
ing block 13 could be prepared via a regioselective opening of the 
benzylidene acetal with borane-tetrahydrofuran complex and cop-
per(II) triflate (Scheme 1).26  
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Scheme 2: Screening for a temporary C6-O protecting group. 
Next a temporary protecting group had to be found which was sta-
ble under glycosylation conditions and during reductive deacetyla-
tion. The first choice was a TIPS ether, which could be introduced 
to give 17a in 93% yield (Scheme 2).27 Glycosylation of the disac-
charide 16 with TIPS donor 17a resulted in several by-products and 
the trisaccharide 18a was isolated in 38% yield (Scheme 2). The 
moderate yield might have resulted from formation of the corre-
sponding 1,6-anhydrosugar during glycosylation, previously ob-
served for C6-O TBDMS protected donors by Bols and co-work-
ers.28 
The TIPS group was substituted with the less acid-labile TBDPS 
group to prevent it from acting as an internal acceptor. Glycosyla-
tion of disaccharide 16 with donor 17b gave trisaccharide 18b in 
71% yield. The acetyl group was deprotected with L-selectride to 
give 19b, which was subjected to a glycosylation with donor 15a 
(Scheme 2). Unfortunately, no conversion of the acceptor was ob-
served, presumably due to the steric demands of the TBDPS ether. 
Therefore, the C6-OH of 13 was protected with an Alloc group by 
reaction with allyl chloroformate and TMEDA (Scheme 2).29 Cou-
pling of 17c to disaccharide acceptor 16 afforded trisaccharide 18c 
in 74% yield even though minor by-products from the reaction be-
tween NIS and the Alloc alkene were observed. Unexpectedly, the 
reduction with L-selectride was not selective even at low tempera-
tures and afforded mainly the diol. 
The final choice of protecting group was an allyl ether. Due to the 
acyl groups, it was not possible to introduce the allyl ether by Wil-
liamson ether synthesis. Instead, a method developed by Sinou and 
co-workers was used where allyl groups can be introduced under 
neutral conditions with allyl ethyl carbonate and bis(dibenzylidene-
acetone)palladium(0) (Scheme 2).30 This made it possible to pre-
pare donor 17d in 83% yield. The glycosylation of acceptor 16 with 
17d turned out to be very slow and several by-products were 
formed, probably from a reaction between the promotor and the al-
kene. Glycosylation mediated by other promotors (1-benzenesulfi-
nyl piperidine (BSP)/Tf2O31, Ph2SO/Tf2O32 or Me2S2/Tf2O33 with 
or without DTBMP) did not give significantly higher yields (33-
65%).  
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Scheme 3. Synthesis of ClAc-protected disaccharide building 
blocks. 
Since no suitable orthogonal protecting group was found, we de-
cided to follow a different strategy. The 3-position was temporarily 
protected with a chloroacetyl group. This made it possible to use an 
acetyl group for the 6-position, which could be removed by L-se-
lectride reduction at the end of the backbone synthesis. The synthe-
sis of the disaccharide donor was performed in analogy to previ-
ously described procedures. The chloroacetyl group was regiose-
lectively introduced in the 3-position via the stannylene acetal to 
afford 9b in excellent yield (Scheme 1). Pivaloyl protection gave 
the fully protected thioglycoside 10b and hydrolysis followed by 
treatment with PTFAICl and Cs2CO3 afforded imidate 12b. The 
thioglycoside 10b could be transformed to acceptor 14 by removal 
of the chloroacetyl group with L-selectride. 
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Scheme 4. Synthesis of heptasaccharide 27 with branching 
point at 3rd residue. 
TMSOTf-catalyzed coupling of 12b with acceptor 14 afforded di-
saccharide 15b in 84% yield (Scheme 3). As it would be unfavora-
ble to have a chloroacetyl in the non-reducing end of the heptasac-
charide, it was changed to Piv to give 20 by reduction with L-se-
lectride followed by pivaloylation. Furthermore, the disaccharide 
donor 15b was converted to acceptor 16 by glycosylation of benzyl 
alcohol followed by deprotection of the chloroacetyl group with L-
selectride (not shown). 
The final building block 21 was prepared by regioselective opening 
of the acetal of 10b followed by acetylation (Scheme 6). 
With all the building blocks in hand, it was now possible to synthe-
size the two heptasaccharides 27 and 33. Trisaccharide 22 was pre-
pared by NIS/TESOTf-promoted coupling of 21 and 16 
(Scheme 4). The new protecting group combination resulted in a 
yield of 75%, but 2.2 equiv. of donor was required in order to obtain 
full conversion of the acceptor.  
Trisaccharide 22 was converted to acceptor 23 by deprotection of 
the chloroacetyl group with thiourea, NaHCO3 and TBAI.34 A sec-
ond glycosylation with disaccharide donor 15b afforded the penta-
saccharide 24 in 80% yield. We were pleased to find that the reac-
tion gave fewer by-products and that only 1.2 equiv. of donor was 
required for full conversion. The chloroacetyl group was removed 
to give acceptor 25, which could be glycosylated with donor 20 to 
obtain the fully protected heptasaccharide 26. Finally, the C6´´-O-
acetyl was removed selectively with L-selectride, affording accep-
tor 27. 
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Scheme 5. Heptasaccharide synthesis with branching point at 
5th residue. 
The second heptasaccharide was synthesized in a similar way 
(Scheme 5). NIS/TESOTf-promoted coupling of disaccharide do-
nor 15b and acceptor 16 afforded tetrasaccharide 28 in 79% yield. 
Deprotection of the chloroacetyl group gave 29, which was reacted 
with monosaccharide donor 21 to give pentasaccharide 30. The 
chloroacetyl group was removed and acceptor 31 was glycosylated 
with donor 20 to give 32. Finally, selective acetyl-deprotection af-
forded the second heptasaccharide acceptor 33. 
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Figure 2. Donors for the synthesis of branched galactans. 
 
Three different side chains were introduced on each heptasaccha-
ride by glycosylation with the thioglycoside donors 20, 3435 and 
3518 shown in Figure 2. All of the glycosylations were promoted by 
NIS/TESOTf in a 1:1 mixture of CH2Cl2 and MeCN at - 30 ˚C 
(Scheme 6 and 7). The two octaasaccharides 36 and 38 and three 
nonasaccharides 37, 39 and 40 were all isolated in yields around 
70%. 
Global deprotection of the linear penta- and heptasaccharide (24 
and 26), two branched octasaccharides (36 and 38) and three nona-
saccharides (37, 39 and 40) was accomplished with Et4NOH and 
subsequent hydrogenolysis over Pd(OH)2/C according to Andersen 
et al.18  
With the target oligosaccharides in hand, we demonstrated their 
usefulness for probing carbohydrate–protein interactions using gly-
can microarrays.36–38 Screening was performed essentially as was 
previously reported.12,18 The data for binding of the two monoclo-
nal antibodies JIM1639 and JIM13340 is presented in Figure 3 and 
 Table 1. Linear and branched β-(1→4)-linked galactans18 were in-
cluded as negative controls. Interestingly, JIM133 bound to all im-
mobilized glycans having a β-(1→3) backbone and the binding in-
tensity was not influenced by branching. In contrast, JIM16 is a 
much more discriminating antibody, requiring branching for bind-
ing and selective for the types of glycans found in the 6-position: 
the mAb recognizes β-(1→3)-Gal2 substitution (compounds 3 and 
4), but not Ara or β-(1→6)-Gal2 branching (compounds 5–6). This 
result also demonstrates the value of including two different types 
of digalactan branching, as the antibody was clearly able to differ-
entiate. As such, JIM133 is useful in e.g. immunofluorescence mi-
croscopy for localizing β-(1→3)-linked galactan in plant tissue. 
41,42 JIM16, on the other hand, is a much more selective antibody, 
which will help pin-point AGP substructures containing branching 
of β-(1→3)-galactan.43 
 
Figure 3. Binding of JIM133 and JIM16 to the synthetic oligo-
saccharides. (A) Fluorescence scan after incubation of the glycan 
microarray with JIM133. The printing pattern of the compounds is 
indicated using pictograms of the oligosaccharides (see legend for 
linkage type of the corresponding next monosaccharide). Each 
compound was printed in four concentrations (200 μM, 50 μM, 
12.5 µM, and 3.1 µM); np: not printed. Oligosaccharide 7 was not 
included due to limited material. (B) Fluorescence scan after incu-
bation of the glycan microarray with JIM16. Compounds were 
printed as indicated in (A). 
Table 1. Microarray data for binding of JIM133 and JIM16 to 
immobilized, synthetic galactans. 
Cmp. 1 2 3 4 5 6 1,4-Gal5 
1,4-
Gal7 
6’’’-Gal 
1,4-Gal7 
6’’’-Ara 
1,4-Gal7 
JIM133 71a 43 26 43 59 60 0 0 0 0 
JIM16 0 0 100 63 0 0 0 0 0 0 
a  Values are normalized signal intensities (relative to the signal from 
JIM16 binding to immobilized 3).
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Scheme 6: Synthesis and deprotection of oligosaccharides with branching point at the 3rd residue. 
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Scheme 7: Glycosylation at 5th residue and following deprotection. 
 
In conclusion, a convergent synthetic strategy for (1→6)-branched 
β-(1→3)-D-galactans was developed and used to prepare octa- and 
nonasaccharides. The substrates have been printed as oligosaccha-
ride microarrays to characterize the epitopes of two plant cell wall-
 directed mAbs. In the future, these well-defined glycans are ex-
pected to yield new insight into the structure and function of arab-
inogalactan proteins in plants.  
EXPERIMENTAL SECTION 
General. All commercial reagents were used as obtained commer-
cially unless otherwise noted. The dry solvents were obtained from 
Innovative Technology PS-MD-7 Pure-solv solvent purification 
system. All of the reactions were carried out in flame-dried glass-
ware under inert atmosphere. Thin-layer chromatography (TLC) 
was performed on Merck Aluminium Sheets pre-coated with silica, 
C-60 F254 plates. Compounds were visualized by charring after 
dipping in CAM stain (Ce(SO4)2 (1.6 g) and (NH4)6Mo7O24 (4 g) in 
10 % sulphuric acid (200 mL). Eluent systems are specified for 
each Rf-value, and ratios are given as volume ratios.  
Evaporation of solvents was performed with a VWR International 
Laborota 400 under reduced pressure (in vacuo) at temperatures 
ranging between 35-55 °C. Trace solvent was removed by under 
reduced pressure by means of an oil pump. Flash chromatography 
was performed using Matrex 60 Å silica gel (35-70 μm) as the sta-
tionary phase by the general procedure developed by Still et al. The 
eluent system is specified under the protocol for each synthesis. El-
uent ratios are given as volume ratios.  
NMR-spectras were recorded at 25 °C on a Bruker Ascend 400, 
Bruker Avance 800 MHz, Varian Mercury 300 B, Bruker DQX 400 
and Bruker AC 500 spectrometer. Chemical shifts (δ) are reported 
in ppm and coupling constants in Hz. Solvents were CDCl3, 
CD3OD, D2O or d6-DMSO and their resonances were used as in-
ternal standards. For D2O, the reference was 4.77, corresponding to 
the HDO signal at 25 °C.44  
IR analysis was done on a Bruker Alpha-P FT-IR instrument where 
solid compound is applied directly onto the instrument. Optical ro-
tation was measured on a Perkin Elmer Model 241 Polarimeter. 
Solvents used were either CHCl3 or H2O.  
High-resolution LC-DAD-MS was performed in an Agilent 1100 
system equipped with a photodiode array detector (DAD) and cou-
pled to a LCT orthogonal time-of-flight mass spectrometer (Wa-
ters-Micromass, Manchester, UK) with Z-spray electrospray ioni-
zation (ESI) source and a LockSpray probe and controlled Mass-
Lynx 4.0 software. LC-MS calibration from m/z 100-900 was done 
with a PEG mixture. Standard separation involved a LUNA 2 col-
umn with a MeCN (50 ppm TFA) in water gradient starting from 
15% to 100% over 25 minutes with a flow rate of 0.3 mL/min. 
High-resolution MALDI-MS was recorded using a Bruker Solarix 
XR 7T ESI/MALDI-FT-ICR-MS run in MALDI+ mode, externally 
calibrated with NaTFA cluster ions and using dithranol as the ma-
trix.  
Most of the compounds have been characterized by NMR and/or 
HRMS. However, N-phenyltrifluoroacetimidates are generally not 
characterized due to low stability. 
 
Phenyl 3-O-acetyl-4,6-O-benzylidene-1-thio-β-D-galactopyra-
noside (9a). Di-n-butyl tin oxide (36.3 g; 145.7 mmol) was added 
to a solution of compound 8 (50.0 g, 138.7 mmol) in dry toluene 
(1000 mL) and stirred under refluxing temperature for 12 h. The 
reaction mixture was cooled to 0 °C, and freshly activated 4Å MS 
(50 g) were added. After 30 min acetyl chloride (10.2 mL, 
142.89 mmol) were added drop wise and stirring was maintained at 
this temperature for 1 h. The reaction was quenched by addition of 
MeOH, filtered through a pad of celite and concentrated. The crude 
product was purified by flash chromatography (4:1 toluene/EtOAc) 
to give 9a as white solid. Rf 0.12 (9:1 Tol/EtOAc). Yield: 49.72 g 
(91%). 1H NMR (400 MHz, CDCl3) δ 7.65 – 7.58 (m, 2H, HSPh), 
7.37 – 7.15 (m, 8H, HSPh, HBn), 5.39 (s, 1H, -CHbenzylidene), 4.83 (dd, 
J2,3 = 9.8, J3,4 = 3.4 Hz, 1H, H-3), 4.51 (d, J1,2 = 9.8 Hz, 1H, H-1), 
4.31 (m, 1H, H-4), 4.29 (dd, J6a,6b = 12.5, J5,6a = 1.3 Hz, 1H, H-6a), 
3.93 (dd, J6a,6b = 12.5, J5,6b = 1.7 Hz, 1H, H-6b), 3.89 (td, J1,2 = J2,3 
=9.8, J2,OH =1.9 Hz, 1H, H-2), 3.52 (m, 1H, H-5), 2.01 (s, 3H, -CH3 
Ac). 13C NMR (101 MHz, CDCl3) δ 171.1, 137.8, 133.8 (2C), 
130.4, 129.2, 129.1 (2C), 128.4, 128.3 (2C), 126.5 (2C), 101.1, 
87.6, 75.0, 73.7, 70.0, 69.3, 65.7, 21.2. HRMS (ESI-TOF) m/z: [M 
+ NH4]+ Calcd for C21H26NO6S 420.1481 Found 420.1478. 
Phenyl 3-O-acetyl-4,6-O-benzylidene-2-O-pivaloyl-1-thio-β-D-
galactopyranoside (10a). Compound 9a (30 g; 74.54 mmol) was 
dissolved in CH2Cl2 (500 mL). Et3N (20.9 mL; 149.1 mmol), 
DMAP (4.55 g; 37.3 mmol) and pivaloyl chloride (9.5 mL; 111.8 
mmol) was added to the solution and the reaction mixture was 
heated to 45 °C for 4 h. The reaction mixture was cooled to 0 °C, 
quenched with MeOH (10 mL), washed with water (2x500 mL), 
dried over MgSO4 and concentrated. The product was purified by 
flash chromatography (Tol/EtOAc 15:1) to afford 10a as a white 
powder. Rf 0.44 (9:1 Tol/EtOAc). Yield 32.0 g (88%). IR (neat, 
cm-1): 3061.41, 2975.48, 2872.21, 1746.23, 1479.26, 1458.20, 
1440.23, 1369.52, 1276.88, 1232.47, 1171.24, 1144.91, 1093.84, 
1048.73, 1025.24. 1H NMR (400 MHz, CDCl3) δ 7.59 – 7.43 (m, 
2H, HSPh), 7.38 – 7.26 (m, 5H, HSPh, Ar-H), 7.25 – 7.14 (m, 3H, Ar-
H), 5.40 (s, 1H, CHbenzylidene), 5.29 (t, J1,2 = J2,3 = 9.9 Hz, 1H, H-2), 
5.01 (dd, J2,3 = 9.9, J3,4 = 3.4 Hz, 1H, H-3), 4.67 (d, J1,2 = 9.9 Hz, 
1H, H-1), 4.30 (dd, J6a,6b = 12.5, J5,6a=1.6 Hz, 1H, H-6a), 4.27 (dd, 
J3,4 = 3.4, J4,5 = 0.9 Hz, 1H, H-4), 3.96 (dd, J6a,6b = 12.4, J5,6b = 1.7 
Hz, 1H, H-6b), 3.52 (m, 1H, H-5), 1.93 (s, 3H, -CH3Ac), 1.14 (s, 
9H, 3xCH3Piv). 13C NMR (101 MHz, CDCl3) δ 176.3, 170.6, 137.5, 
133.6 (2C), 131.6, 129.1, 128.8 (2C), 128.1 (2C), 128.1, 126.5 
(2C), 101.0, 85.5, 73.7, 73.0, 69.7, 69.1, 66.2, 38.7, 27.1, 20.8 (3C). 
HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for C26H30NaO7S 
509.1610; Found 509.1595. 
3-O-Acetyl-4,6-O-benzylidene-2-O-pivaloyl-D-galactopyranose 
(11a). Compound 10a (20.0 g; 41.1 mmol) was dissolved in MeCN 
(270 mL) and water (30 mL). NBS (29.3 g; 164.4 mmol) and 2,6-
lutidine (23.8 mL; 205.5 mmol) were added and the reaction was 
stirred at 50 °C until TLC showed full conversion (2 h). The solu-
tion was diluted with CH2Cl2 (500 mL) and washed with sat. aq. 
NaS2O3 (200 mL) and sat. aq. NaHCO3 (200 mL). The organic 
phase was dried over MgSO4, filtered and concentrated. The prod-
uct was purified by flash chromatography (6:1 Tol/EtOAc) to af-
ford 11a as α/β mixture. Rf 0.12 (9:1 Tol/EtOAc). Yield: 17.2 g 
(84%). IR (neat, cm-1): 3468.40, 2974.49, 2934.27, 2909.50, 
2873.74, 1737.61, 1479.91, 1457.72, 1369.67, 1240.78, 1115.19, 
1093.82, 1025.30, 977.04. 1H NMR (400 MHz, CDCl3) δ 7.43 (m, 
2H, Ar-H), 7.30 (m, 3H, Ar-H), 6.31 (d, J1,2 = 3.6 Hz, 1H, H-1), 
5.45 (s, 1H, Hbenzylidene), 5.08 (dd, J2,3 = 10.5, J3,4 = 3.4 Hz, 1H, H-
3), 4.42 (dd, J3,4 = 3.4, J4,5 = 1.2 Hz, 1H, H-4), 4.35 (dd, J2,3 = 10.5, 
J1,2 = 3.6 Hz, 1H, H-2), 4.22 (dd, J6a,6b = 12.6, J5,6a = 1.6 Hz, 1H, H-
6a), 3.97 (dd, J6a,6b = 12.6, J5,6b = 1.8 Hz, 1H, H-6b), 3.75 (m, 1H, 
H-5), 2.09 (s, 3H, CH3Ac), 1.20 (s, 9H, 3xCH3Piv). 13C NMR (101 
MHz, CDCl3) δ 177.0, 171.7, 137.5, 129.2, 128.4, 126.3, 100.9, 
92.8, 73.8, 71.7, 69.1, 66.0, 64.7, 39.5, 27.3, 21.2. HRMS (ESI-
TOF) m/z: [M + Na]+ Calcd for C20H26NaO8: 417.1525; Found 
417.1529. 
3-O-Acetyl-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nose N-phenyl trifluoroacetimidate (12a). Compound 11a (13 g; 
33.0 mmol) was dissolved in CH2Cl2 (300 mL) and cooled to 0 °C. 
Cs2CO3 (21.5 g; 65.9 mmol) was added followed by N-phenyl tri-
fluoroacetimidoyl chloride (13.7 g; 65.9 mmol). The ice bath was 
removed and the reaction mixture was stirred until TLC showed 
full conversion (5 h). It was then filtered, concentrated and purified 
by flash chromatography (20:1 Tol/EtOAc) to give an off-white 
solid. Rf 0.66 (9:1 Tol/EtOAc) Yield: 14.7 g (79%). 
 Phenyl 4,6-O-benzylidene-2-O-pivaloyl-1-thio-β-D-galactopy-
ranoside (14). Compound 10a (10 g; 20.6 mmol) was dissolved in 
dry CH2Cl2 (200 mL) and cooled to 0 °C. A 1 M L-selectride solu-
tion in THF (61.6 mL) was added and the reaction was stirred at 0 
°C until complete consumption of the starting material (4 h). The 
reaction mixture was poured into sat. aq. NH4Cl (400 mL). The or-
ganic phase was dried over MgSO4, filtered and concentrated 
(avoid concentrating to dryness since the borane salts can be explo-
sive). The crude product was purified by flash chromatography (9:1 
Tol/EtOAc) to give an off-white solid. Rf 0.23 (9:1 Tol/EtOAc) 
Yield: 8.6 g (94%). 1H NMR (400 MHz, CDCl3) δ 7.51 (m, 2H, 
Ar-H), 7.38 – 7.10 (m, 10H, Ar-H), 5.45 (s, 1H, CHbenzylidene), 4.98 
(t, J1,2 = J2,3 = 9.7 Hz, 1H, H-2), 4.60 (d, J1,2 = 9.7 Hz, 1H, H-1), 
4.31 (dd, J6a,6b = 12.5, J5,6a =1.5 Hz, 1H, H-6a), 4.14 (dd, J3,4 = 3.6, 
J4,5 =1.1 Hz, 1H, H-4), 3.96 (dd, J6a,6b = 12.5, J5,6b = 1.7 Hz, 1H, H-
6b), 3.67 (dd, J2,3 = 9.7, J3,4 = 3.6 Hz, 1H, H-3), 3.51 – 3.43 (m, 1H, 
H-5), 1.19 (s, 9H, 3xCH3Piv). 13C NMR (101 MHz, CDCl3) δ 177.6, 
137.4, 133.6 (2C), 131.6, 129.4, 128.8 (2C), 128.2 (2C), 128.1, 
126.5 (2C), 101.4, 85.1, 75.7, 72.9, 69.9, 69.5, 69.2, 38.8, 27.2 
(3C). HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for C24H28NaO6S: 
467.1504; Found 467.1511. 
Phenyl 3-O-acetyl-4,6-O-benzylidene-2-O-pivaloyl-β-D-galacto-
pyranosyl-(1→3)- 4,6-O-benzylidene-2-O-pivaloyl-1-thio-β-D-
galactopyranoside (15a). To a 500 mL flame-dried flask was 
added 14 (7.0 g, 15.7 mmol) and the 12a (11.4 g, 20.5 mmol). The 
mixture was co-evaporated with toluene (2x200 mL) and subjected 
to vacuum overnight. The mixture dissolved in CH2Cl2 (200 mL) 
and cooled to -40 °C. TMSOTf (0.24 mL; 1.6 mmol) was added 
and the reaction mixture was stirred at -40 °C (1 h). Et3N (1 mL) 
was added and the reaction mixture was concentrated. The crude 
compound was purified by flash chromatography (9:1 Tol/EtOAc) 
affording 15a. Rf 0.23 (9:1 Tol/EtOAc). Yield: 11.9 g (92%). 
1H NMR (400 MHz, CDCl3) δ 7.48 – 7.36 (m, 6H, Ar-H, HSPh), 
7.27 (m, 6H, , Ar-H, HSPh), 7.20 – 7.06 (m, 3H, Ar-H, HSPh), 5.48 
(s, 1H, -CHbenzylidene), 5.43 (s, 1H, -CHbenzylidene), 5.33 (dd, J2,3 = 
10.6, J1,2 = 8.0 Hz, 1H, H-12), 5.30 (t, J1,2 =J2,3 = 9.8 Hz, 1H, H-21), 
4.85 (d, J = 8.0 Hz, 1H, H-12), 4.82 (dd, J2,3 = 10.6, J2,3 = 3.6 Hz, 
1H, H-32), 4.59 (d, J = 9.8 Hz, 1H, H-11), 4.33 – 4.14 (m, 5H, H-
31, H-41/2, H-41/2, H-6a1, H-6a2), 3.98 (dd, J6a,6b = 12.5, J5,6b 
=1.8 Hz, 1H, H-6b1), 3.92 (dd, J6a,6b = 12.5, J5,6b =1.7 Hz, 1H, H-
6b2), 3.40 – 3.36 (m, 1H, H-51/2), 3.36 (s, 1H, H-51/2), 1.95 (s, 3H, 
CH3Ac), 1.22 (s, 9H, 3xCH3Piv), 1.00 (s, 9H, 3xCH3Piv). 13C NMR 
(101 MHz, CDCl3) δ 176.8, 176.1, 170.6, 137.9, 137.5, 133.5, 
132.3 (2C), 129.1, 128.7 (2C), 128.6 (2C), 128.2 (2C), 127.9 (2C), 
127.6, 126.24 (2C), 126.21, 100.8, 100.1, 99.4, 86.8, 75.9, 73.6, 
73.6, 71.8, 70.2, 69.4, 68.9, 68.8, 68.2, 66.6, 38.8, 38.7, 27.4 (3C), 
27.0 (3C), 20.80. HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for 
C44H52NaO13S: 843.3026; Found 843.3014. 
Benzyl 3-O-acetyl-4,6-O-benzylidene-2-O-pivaloyl-β-D-galacto-
pyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galacto-
pyranoside (41). Compound 15a (2.0 g; 2.4 mmol) was dried aze-
otropically with toluene (2x20 mL) and subjected to vacuum over-
night. Benzyl alcohol (0.8 g; 7.3 mmol) was added. The mixture 
was dissolved in dry CH2Cl2 (50 mL) and cooled to -40 °C. NIS 
(602 mg; 2.7 mmol) and TESOTf (64 mg; 0.24 mmol) was added 
and the reaction mixture was stirred at -40 °C until TLC revealed 
full conversion of the donor (2 h). The solution was diluted with 
CH2Cl2 (100 mL) and washed with sat. aq. NaS2O3 (100 mL) and 
sat. aq. NaHCO3 (100 mL). The organic phase was dried over 
MgSO4, filtered and concentrated. The product was purified by 
flash chromatography (9:1 toluene/EtOAc) to afford 41 as an off-
white solid. Rf 0.10 (9:1 Tol/EtOAc) Yield: 1.5 g (75%). IR (neat, 
cm-1): 3524.57, 3065.71, 2973.85, 1733.56, 1497.34, 1479.42, 
1454.83, 1398.37, 1278.46, 1249.26, 1167.19, 1139.04, 1087.54, 
1060.73. 1H NMR (400 MHz, CDCl3) δ 7.51 – 7.38 (m, 4H, HSPh), 
7.35 – 7.13 (m, 11H, HSPh, Ar-H), 5.51 (s, 1H, -CHbenzylidene), 5.43 
(s, 1H, -CHbenzylidene), 5.42 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2), 
5.35 (dd, J2,3 = 10.6, J1,2 = 8.1 Hz, 1H, H-2’), 4.93 (d, J1,2 = 8.1 Hz, 
1H, H-1’), 4.87 – 4.79 (m, 2H, H-3’, -CH2Bn), 4.47 (d, J = 11.9 Hz, 
1H, -CH2Bn), 4.37 (d, J = 7.9 Hz, 1H, H-1), 4.34 – 4.23 (m, 4H, H-
4’,H-4, H-6a’, H-6b’), 4.13 (dd, J2,3 = 10.4, J3,4 = 3.4 Hz, 1H, H-3), 
3.99 (m, 2H, H-6a, H-6b), 3.42 – 3.26 (m, 2H, H-5,H-5’), 1.96 (s, 
3H, -CH3Ac), 1.10 (s, 9H, 3xCH3Piv), 1.05 (s, 9H, 3xCH3Piv). 13C 
NMR (101 MHz, CDCl3) δ 176.8, 176.1, 170.7, 137.8, 137.5, 
137.2, 129.08, 129.05, 128.6, 128.24, 128.22, 128.20, 127.96 (2C), 
127.8 (2C), 127.5, 126.3 (2C), 126.1 (2C), 100.8, 100.3, 100.2, 
99.5, 75.9, 73.6, 72.7, 71.9, 70.8, 69.9, 68.83, 68.77, 68.2, 66.9, 
66.7, 38.8, 38.7, 27.22, 27.19, 27.19, 27.08 (3C), 27.0 (3C), 20.8. 
HRMS (ESI-TOF) m/z: [M + NH4]+ Calcd for C45H58NO14 
836.3857 Found 836.3843. 
Benzyl 4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-
(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside 
(16). Compound 41 (1.5 g; 1.8 mmol) was dissolved in dry CH2Cl2 
(30 mL) and cooled to 0 °C. A 1 M L-selectride solution in THF 
(5.5 mL) was added and the reaction was stirred at 0 °C until com-
plete consumption of the starting material (5 h). The reaction mix-
ture was poured into sat. aq. NH4Cl (100 mL). The organic phase 
was dried over MgSO4, filtered and concentrated (avoid concen-
trating to dryness since the borane salts can be explosive). The 
crude product was purified by flash chromatography (6:1 
Tol/EtOAc) yielding 16 as an off-white solid. Rf 0.46 (2:1 
Tol/EtOAc). Yield: 1.28 g (90%). 1H NMR (400 MHz, CDCl3) δ 
7.51 – 7.13 (m, 15H, Ar-H), 5.49 (s, 1H, CHbenzylidene), 5.47 (s, 1H, 
CHbenzylidene), 5.45 (dd, J2,3 = 10.1, J1,2 = 7.9 Hz, 1H, H-21), 5.00 (dd, 
J2,3 = 10.1, J1,2 = 8.0 Hz, 1H, H-22), 4.84 (d, JCH2 = 11.8 Hz, 1H, 
CH2Bn), 4.84 (d, J1,2 = 8.0 Hz, 1H, H-12), 4.48 (d, JCH2 = 11.9 Hz, 
1H, CH2Bn), 4.39 (d, J1,2 = 7.9 Hz, 1H, H-11), 4.31 – 4.23 (m, 3H, 
H-41, H-6a2, H-6b2), 4.10 (d, J3,4 = 3.7 Hz, 1H, H-42), 4.08 (dd, J2,3 
= 10.1, J3,4 = 3.2 Hz, 1H, H-31), 4.02 – 3.95 (m, 2H, H-6a1, H-6b1), 
3.52 (dd, J2,3 = 10.1, J3,4 = 3.7 Hz, 1H, H-32), 3.34 (s, 1H, H-51), 
3.33 (s, 1H, H-52), 1.10 (s, 9H, 3xCH3Piv), 1.10 (s, 9H, 3xCH3Piv). 
13C NMR (101 MHz, CDCl3) δ 179.0, 176.2, 137.9, 137.5, 137.3, 
129.3, 129.1, 128.8, 128.4, 128.38, 128.34 (2C), 128.0, 127.9 (2C), 
127.6 (2C), 126.4 (2C), 126.3, 101.3, 100.5, 100.4, 99.5, 76.1, 75.8, 
73.2, 72.3, 72.2, 71.0, 70.0, 68.9, 67.0, 66.9, 39.0, 38.8, 27.3 (3C), 
27.1 (3C). HRMS (ESI-TOF) m/z: [M + NH4]+ Calcd for 
C43H56NO13 794.3752 Found 794.3756. 
Phenyl 3-O-acetyl-4-O-benzyl-2-O-pivaloyl-1-thio-β-D-galacto-
pyranoside (13). A 1 M solution of BH3·THF complex in THF 
(61.6 mL) was added to a solution of 10a (6 g; 12.33 mmol) in 
CH2Cl2 (50 mL) at 0 °C. The mixture was stirred for 10 min, and 
freshly dried Cu(OTf)2 (669 mg, 1.85 mmol) was added to the so-
lution. After stirring for a 5 h, the mixture was cooled to 0 °C, and 
the reaction was quenched by addition of Et3N (1.7 mL, 
12.33 mmol) and methanol (30 mL, caution: hydrogen gas was 
evolved). The resultant mixture was concentrated at reduced pres-
sure followed by coevaporation with methanol. The residue was 
purified by flash chromatography (9:1 Tol/EtOAc). Rf 0.15 (9:1 
Tol/EtOAc). Yield: 4.79 g (80%). 1H NMR (400 MHz, CDCl3) δ 
7.45 – 7.35 (m, 2H, HSPh), 7.32 – 7.14 (m, 8H, HSPh, HBn), 5.36 (dd, 
J1,2 = J2,3 =10.0 Hz, 1H, H-2), 5.00 (dd, J2,3 = 10.0, J3,4 = 3.0 Hz, 
1H, H-3), 4.68 (d, JCH2= 11.7 Hz, 1H, -CH2Bn), 4.65 (d, J1,2 = 10.0 
Hz, 1H, H-1), 4.44 (d, JCH2 = 11.7 Hz, 1H, -CH2Bn), 3.86 (dd, J3,4 = 
3.0, J4,5 =1.0 Hz, 1H), 3.77 (ddd, J6a,6b = 11.0, J5,6a = 6.7, J6a,OH =3.9 
Hz, 1H, H-6a), 3.59 – 3.50 (m, 1H, H-5), 3.48 (ddd, J6a,6b = 11.1, 
J5,6b = 8.6, J6b,OH = 5.2 Hz, 1H, H-6b), 1.92 (s, 3H, -CH3Ac), 1.14 
(s, 9H, 3xCH3Piv). 13C NMR (101 MHz, CDCl3) δ 176.7, 170.2, 
137.5, 133.2, 132.0 (2C), 128.9 (2C), 128.5 (2C), 128.3 (2C), 
128.1, 127.8, 86.9, 78.9, 75.0, 74.7, 73.8, 67.5, 61.8, 38.8, 27.0 
 (3C), 20.8. HRMS (ESI-TOF) m/z: [M+NH4]+ Calcd for 
C26H36NO7S 506.2213 Found 506.2228.  
Phenyl 3-O-acetyl-4-O-benzyl-2-O-pivaloyl-6-O-triisopropylsi-
lyl-1-thio-β-D-galactopyranoside (17a). Compound 13 (1.3 g; 
2.66 mmol) was dissolved in DMF (25 mL) and cooled to 0 °C. To 
the solution were added triisopropylsilyl chloride (0.85 mL; 3.99 
mmol) and imidazole (0.36 g; 5.32 mmol). The reaction mixture 
was stirred at 0 °C for 1 h and then at 22 °C for 18h. The mixture 
was diluted with Et2O (200 mL) and washed with water (3x200 
mL). The organic phase was dried over MgSO4, filtered, concen-
trated and purified by flash chromatography (20:1 Tol/EtOAc) to 
give 17a as a white solid. Rf 0.63 (9:1 Tol/EtOAc). Yield: 1.58 g 
(93%). IR (neat, cm-1): 3061.27, 3032.58, 2865.93, 1745.83, 
1584.53, 1496.52, 1479.01, 1461.73, 1366.26, 1276.30, 1231.32, 
1147.24, 1113.13, 1077.71, 1047.98. 1H NMR (400 MHz, CDCl3) 
δ 7.46 – 7.34 (m, 2H, Ar-H), 7.35 – 7.07 (m, 8H, Ar-H), 5.34 (t, J1,2 
= J2,3 = 10.0 Hz, 1H, H-2), 5.04 (dd, J2,3 = 10.0, J3,4 = 3.0 Hz, 1H, 
H-3), 4.67 (d, JCH2 = 11.6 Hz, 1H, 0.5xCH2Bn), 4.56 (d, J = 11.6 Hz, 
1H, 0.5xCH2Bn), 3.97 (dd, J3,4 = 3.1, J4,5 = 1.0 Hz, 1H, H-4), 3.87 – 
3.66 (m, 2H, H-6a, H-6b), 3.57 (ddd, J5,6a = 7.2, J5,6b =5.9, J4,5 =1.0 
Hz, 1H, H-5), 1.85 (s, 3H, CH3Ac), 1.12 (s, 9H, 3xCH3Piv), 0.98 (s, 
6H, CH3TIPS). 13C NMR (101 MHz, CDCl3) δ 176.8, 170.4, 138.3, 
133.6, 132.0 (2C), 128.9 (2C), 128.4 (2C), 128.0 (2C), 127.7, 
127.7, 86.9, 79.3, 75.0, 74.2, 67.8, 61.7, 38.9, 27.2 (3C), 20.9, 18.1 
(2C), 18.1 (2C), 17.8, 12.4, 12.0 (2C). HRMS (ESI-TOF) m/z: 
[M+Na]+ Calcd for C35H52NaO7SSi 667.3101 Found 667.3098. 
Benzyl 3-O-acetyl-4-O-benzyl-6-O-triisopropylsilyl-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranoside (18a). To a 50 mL flame-dried 
flask was added 16 (0.92 g, 1.18 mmol) and 17a (1.14 g, 
1.78 mmol). The mixture was dried azeotropically with toluene 
(2x20 mL) and subjected to vacuum overnight. It was then dis-
solved in dry CH2Cl2 (10 mL) and dry MeCN (10 mL), cooled 
to -30 °C, followed by addition of NIS (413 mg; 1.84 mmol) and 
TESOTf (63 mg; 0.24 mmol). The reaction mixture was stirred at -
30 °C until TLC revealed full conversion of the donor (1 h). The 
solution was diluted with CH2Cl2 (100 mL) and washed with sat. 
aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic 
phase was dried over MgSO4, filtered and concentrated. The prod-
uct was purified by flash chromatography (12:1 toluene/EtOAc) to 
afford an off-white solid. Yield: 590 mg (38%). Rf 0.46 (9:1 
Tol/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.56 – 7.01 (m, 20H, 
Ar-H), 5.48 (s, 1H, CHbenzylidene), 5.46 (s, 1H, CHbenzylidene), 5.39 
(dd, J2,3 = 10.3, J1,2 = 7.8 Hz, 1H, H-2), 5.31 (dd, J2,3 = 10.1, J1,2 = 
8.1 Hz, 1H, H-2), 5.27 (dd, J2,3 = 10.5, J1,2 = 8.0 Hz, 2H), 4.84 (dd, 
J2,3 = 10.6, J3,4 = 3.1 Hz, 1H, H-33), 4.82 (d, JCH2 = 11.9 Hz, 1H, 
CH2Bn), 4.71 (d, J1,2 = 1 Hz, 1H, H-1), 4.70 (d, J1,2 = 8.0 Hz, 1H, H-
1), 4.70 (d, JCH2 = 12.2 Hz, 1H, 0.5xCH2Bn), 4.65 (d, JCH2 = 11.9 
Hz, 1H, 0.5xCH2Bn), 4.55 (d, JCH2 = 11.3 Hz, 1H, 0.5xCH2Bn), 4.45 
(d, JCH2 = 11.9 Hz, 1H, 0.5xCH2Bn), 4.37 (d, J1,2 = 7.8 Hz, 1H, H-
1), 4.31 – 4.21 (m, 2H, H-6), 4.20 (d, J3,4 = 3.5 Hz, 1H, H-4), 4.15 
(d, J3,4 = 3.4 Hz, 1H, H-4), 4.12 (d, J3,4 = 3.4 Hz, 1H, H-4), 4.06 – 
3.91 (m, 5H, 3xH-3, H-6), 3.81 (m, 1H, H-6a3), 3.71 (m, 1H, H-
6b3), 3.47 (dd, J5,6a = 8.7, J5,6b = 5.5 Hz, 1H, H-53), 3.31 (s, 1H, H-
5), 3.27 (s, 1H, H-5), 1.83 (s, 3H, CH3Ac), 1.07 (s, 9H, 3xCH3Piv), 
1.06 (s, 9H, 3xCH3Piv), 1.03 – 0.96 (m, 27H, 3xCH3Piv, 6xCH3TIPS), 
0.99 (m, 3H, 3xCHTIPS). 13C NMR (101 MHz, CDCl3) δ 177.2, 
176.1, 175.9, 170.3, 138.2, 137.9, 137.7, 137.3, 128.6-126.0 (20C), 
100.21, 100.18, 100.1, 100.0, 99.4, 78.9, 77.7, 77.3, 75.7, 75.6, 
75.3, 75.3, 74.8, 74.1, 74.0, 73.7, 73.5, 71.7, 71.4, 69.9, 69.3, 68.8, 
68.7, 67.3, 67.0, 66.7, 60.9, 60.8, 38.7, 38.6, 38.6, 27.20 (3C), 
27.18 (3C), 27.0 (3C), 20.7, 18.1 (3C), 18.1 (3C), 18.03 (3C), 18.02 
(3C), 18.00 (3C), 17.96 (3C), 11.85, 11.85, 11.83. 
Benzyl 4-O-benzyl-6-O-triisopropylsilyl-2-O-pivaloyl-β-D-ga-
lactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-ga-
lactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-ga-
lactopyranoside (19a). Compound 18a (350 mg; 0.27 mmol) was 
dissolved in dry CH2Cl2 (10 mL) and cooled to 0 °C. A 1 M L-se-
lectride solution in THF (1.1 mL) was added and the reaction was 
stirred at 0 °C until complete consumption of the starting material 
was observed by TLC (3 h). The reaction mixture was poured into 
sat. aq. NH4Cl (100 mL) and extracted with CH2Cl2 (2x50 mL). 
The combined organic phases were dried over MgSO4, filtered and 
concentrated (avoid concentrating to dryness since the borane salts 
can be explosive). The crude product was purified by flash chro-
matography (9:1 Tol/EtOAc) to give an off-white solid. Yield: 0.31 
g (92%). Rf 0.40 (9:1 Tol/EtOAc). 1H NMR (400 MHz, CDCl3) δ 
7.54 – 7.31 (m, 4H, Ar-H), 7.35 – 7.05 (m, 16H, Ar-H), 5.49 (s, 
1H, CHbenzylidene), 5.43 (s, 1H, CHbenzylidene), 5.40 (dd, J2,3 = 10.1, J1,2 
= 7.7 Hz, 1H, H-2), 5.35 (dd, J2,3 = 10.0, J1,2 = 7.8 Hz, 1H, H-2), 
4.84 (dd, J2,3 = 9.6, J1,2 = 7.4 Hz, 1H, H-2), 4.83 (d, JCH2 = 12.1 Hz, 
1H, 0.5xCH2Bn), 4.73 – 4.71 (m, 2H, CH2Bn), 4.69 (d, J1,2 = 7.7 Hz, 
1H, H-1), 4.64 (d, J1,2 = 7.8 Hz, 1H, H-1), 4.45 (d, JCH2 = 11.9 Hz, 
1H, 0.5xCH2Bn), 4.37 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.31 – 4.20 (m, 
3H, H-4, H-6), 4.18 – 4.12 (m, 2H, H-3, H-4), 4.02 – 3.93 (m, 3H, 
H-3, H-6), 3.88 (dd, J3,4 = 3.5 Hz, J4,5 = 1.0 Hz, 1H, H-4), 3.82 (dd, 
J6a,6b = 9.7, J5,6a = 8.6 Hz, 1H, H-6a), 3.75 (dd, J6a,6b = 9.7, J5,6b = 
5.5 Hz, 1H, H-6b), 3.46 (dd, J2,3 = 9.7, J3,4 = 3.5 Hz, 1H, H-3), 3.37 
(ddd, J5,6a = 8.6, J5,6b = 5.5, J4,5 =1.1 Hz, 1H, H-5), 3.32 (d, J = 1.3 
Hz, 1H, H-5), 3.29 (d, J = 1.4 Hz, 1H, H-5), 1.08 (s, 9H, 3xCH3Piv), 
1.06 (s, 9H, 3xCH3Piv), 1.04 (s, 9H, 3xCH3Piv), 1.00 (s, 18H, 
6xCH3TIPS), 0.99 (m, 3H, 3xCHTIPS). 13C NMR (101 MHz, CDCl3) 
δ 177.6, 176.10, 176.06, 137.9, 137.8, 137.34, 137.32, 127.6-125.1 
(20C), 99.3, 99.2, 99.1, 98.9, 98.3, 75.2, 74.8, 74.7, 74.6, 74.3, 
72.6, 72.5, 70.8, 70.74, 70.71, 70.0, 68.9, 67.72, 67.69, 66.3, 65.9, 
26.2 (3C), 26.1 (3C), 25.9 (3C), 17.1 (2C), 17.05 (2C), 17.02 (2C), 
10.8 (3C). 
Phenyl 3-O-acetyl-6-O-allyloxycarbonyl-4-O-benzyl-2-O-
pivaloyl-1-thio-β-D-galactopyranoside (17c). TMEDA (0.18 mL; 
1.22 mmol) and allyl chloroformate (0.24 mL; 2.25 mmol) were 
added to a solution of 13 (1.0 g; 2.05 mmol) in anhydrous CH2Cl2 
(25 mL) at 0 °C. After 1h the mixture was diluted with CH2Cl2 (75 
mL), washed with water (100 mL), dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography 
(15:1 Tol/EtOAc) to give compound 17c. Rf 0.51 (9:1 Tol/EtOAc). 
Yield: 8.3 g (91%). IR (neat, cm-1): 3062.34, 2972.29, 2936.14, 
2905.97, 1743.53, 1584.14, 1496.611455.38, 1440.49, 1366.40, 
1256.83, 1230.13, 1143.53, 1084.39. 1H NMR (400 MHz, CDCl3) 
δ 7.48 – 7.36 (m, 2H, Ar-H), 7.34 – 7.09 (m, 8H, Ar-H), 5.85 (ddt, 
Jtrans = 17.2, Jcis = 10.4, JCH2 = 5.8 Hz, 1H, -CH=CH2), 5.34 (t, J1,2 
= J2,3 = 10.1 Hz, 1H, H-2), 5.29 (dq, Jtrans = 17.2, JCH2 = 1.4 Hz, 1H, 
CH2=CHtrans), 5.21 (dd, Jcis = 10.4, JCH2 = 1.3 Hz, 1H, 
CH2=CHtrans), 5.00 (dd, J2,3 = 10.0, J3,4 = 2.9 Hz, 1H, H-3), 4.68 (d, 
JCH2 = 11.6 Hz, 1H, CH2Bn), 4.62 (d, J1,2 = 10.0 Hz, 1H, H-1), 4.54 
(dt, JCH=CH2 = 5.8, JCH2=CH = 1.4 Hz, 2H, CH2allyl), 4.47 (d, JCH2 = 
11.6 Hz, 1H, CH2Bn), 4.31 (dd, J6a,6b = 11.0, J5,6a = 6.4 Hz, 1H, H-
6a), 4.05 (dd, J6a,6b = 11.0, J5,6b = 6.4 Hz, 1H, H-6b), 3.88 (dd, J3,4 
= 3.0, J4,5 = 1.0 Hz, 1H, H-4), 3.74 (td, J5,6b = J5,6a = 6.4, J4,5 =1.1 
Hz, 1H, H-5), 1.91 (s, 3H, CH3Ac), 1.14 (s, 9H, 3xCH3Piv). 13C 
NMR (101 MHz, CDCl3) δ 176.8, 170.2, 154.6, 137.5, 133.1, 
132.5 (2C), 131.4, 129.0 (2C), 128.6 (2C), 128.2 (2C), 128.1, 
128.0, 119.3, 87.1, 75.9, 75.0, 74.8, 73.9, 68.9, 67.4, 65.8, 38.9, 
27.1 (3C), 20.8. HRMS (ESI-TOF) m/z: [M+Na]+ Calcd for 
C30H36NaO9S 595.1978 Found 595.1978. 
Benzyl 3-O-acetyl-4-O-benzyl-6-O-allyloxocarbonyl-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranoside (18c). To a 25 mL flame-dried 
 flask was added 16 (1.0 g, 1.29 mmol) and the 17c (0.96 mg, 
1.67 mmol). The mixture was dried azeotropically with toluene 
(2x10 mL) and subjected to vacuum overnight. It was then dis-
solved in dry CH2Cl2 (5 mL) and dry MeCN (5 mL), cooled 
to -30 °C, followed by addition of NIS (385 mg; 1.71 mmol) and 
TESOTf (34 mg; 0.13 mmol). The reaction mixture was stirred 
at -30 °C until TLC revealed full conversion of the donor (2 h). The 
solution was diluted with CH2Cl2 (100 mL) and washed with sat. 
aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic 
phase was dried over MgSO4, filtered and concentrated. The prod-
uct was purified by flash chromatography (9:1 toluene/EtOAc) to 
afford 18c as an off-white solid. Yield: 1.14 g (74%). 1H NMR 
(400 MHz, CDCl3) δ 7.43 (m, 4H, Ar-H), 7.39 – 7.05 (m, 16H, Ar-
H), 5.86 (ddt, Jtrans = 17.2, Jcis = 10.3, JCH2 = 5.9 Hz, 1H, -
CH=CH2), 5.48 (s, 2H, 2xCHbenzylidene), 5.38 (dd, J2,3 = 10.1, J1,2 = 
7.7 Hz, 1H, H-2), 5.33 (dd, J2,3 = 10.2, J1,2 = 7.8 Hz, 1H, H-2), 5.30 
(dd, Jtrans = 17.2, JCH2 = 1.5 Hz, 1H, CH2=CH-), 5.28 (dd, J2,3 = 
10.9, J1,2 = 7.0 Hz, 1H, H-2), 5.23 (dq, Jcis = 10.4, JCH2 = 1.2 Hz, 
1H, CH2=CH-), 4.83 (dd, J2,3 = 10.9, J3,4 = 3.6 Hz, 1H, H-3), 4.82 
(d, JCH2 = 11.7 Hz, 1H), 4.72 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.70 (d, 
J1,2 = 7.0 Hz, 1H, H-1), 4.67 (d, JCH2 = 11.5 Hz, 1H, CH2Bn), 4.55 
(m, 2H, CH2Alloc), 4.45 (d, JCH2 = 12.0 Hz, 1H, CH2Bn), 4.44 (d, JCH2 
= 11.4 Hz, 1H, 0.5xCH2Bn), 4.37 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.31 – 
4.19 (m, 3H, 1.5xH-6), 4.24 (d, J3,4 = 3.5 Hz, 1H, H-4), 4.21 (dd, 
J3,4 = 3.8, J4,5 = 1.2 Hz, 1H, H-4), 4.14 (dd, J2,3 = 9.8, J3,4 = 3.0 Hz, 
1H, H-3), 4.10 (dd, J6a,6b = 11.1, J5,6a = 5.9 Hz, 1H, H-6a), 4.00 (m, 
2H, H-6), 3.95 (dd, J2,3 = 10.5, J3,4 = 3.4 Hz, 1H, H-3), 3.86 (dd, J3,4 
= 3.1, J4,5 = 1.5 Hz, 1H, H-4), 3.67 (td, J5,6a = 5.9, J5,6a = 1.5 Hz, 
1H, H-5), 3.34 – 3.27 (m, 2H, 2xH-5), 1.89 (s, 3H, CH3Ac), 1.09 (s, 
8H, 3xCH3Piv), 1.05 (s, 9H, 3xCH3Piv), 1.01 (s, 9H, 3xCH3Piv). 13C 
NMR (101 MHz, CDCl3) δ 177.1, 176.2, 176.1, 170.3, 154.7, 
138.0, 137.8, 137.38, 137.37, 131.4-126.1 (20C), 119.5, 100.4, 
100.3, 100.2, 100.0, 99.9, 75.81, 75.76, 75.1, 73.8, 73.2, 72.8, 72.7, 
71.9, 71.8, 70.9, 70.0, 68.9, 68.8, 67.4, 67.1, 66.0, 38.9, 38.8, 38.7, 
27.3 (6C), 27.1 (3C), 20.8. HRMS (ESI-TOF) m/z: [M + Na]+ 
Calcd for C67H82NaO22: 1261.5195; Found 1261.5197. 
Benzyl 3-O-acetyl-4-O-benzyl-2-O-pivaloyl-6-O-(tert-butyldi-
phenylsilyl)-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-
O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-
O-pivaloyl-β-D-galactopyranoside (18b). To a 25 mL flame-dried 
flask was added 16 (800 mg, 1.03 mmol) and the 17b (1050 mg, 
1.45 mmol). The mixture was dried azeotropically with toluene 
(2x10 mL) and subjected to vacuum overnight. It was then dis-
solved in dry CH2Cl2 (5 mL) and dry MeCN (5 mL), cooled 
to -30 °C, followed by addition of NIS (333 mg; 1.48 mmol) and 
TESOTf (54 mg; 0.21 mmol). The reaction mixture was stirred 
at -30 °C until TLC revealed full conversion of the donor (2 h). The 
solution was diluted with CH2Cl2 (100 mL) and washed with sat. 
aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic 
phase was dried over MgSO4, filtered and concentrated. The prod-
uct was purified by flash chromatography (9:1 toluene/EtOAc) to 
afford an off-white solid. Yield: 1.02 g (71%). 1H NMR (400 MHz, 
CDCl3) δ 7.55 (m, 4H, Ar-H), 7.51 – 7.04 (m, 32H, Ar-H), 5.47 (s, 
1H, Hbenzylidene), 5.42 (s, 1H, Hbenzylidene), 5.34 (dd, J2,3 = 10.3, J1,2 = 
7.9 Hz, 1H), 5.26 (dd, J2,3 = 10.7, J1,2 = 7.9 Hz, 1H, H-1), 5.25 (dd, 
J2,3 = 10.6, J1,2 = 7.9 Hz, 1H, H-1), 4.85 (dd, J2,3 = 10.6, J3,4 = 3.1 
Hz, 1H, H-3), 4.81 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2Bn), 4.68 (d, 
JCH2 = 11.3 Hz, 1H, 0.5xCH2Bn), 4.64 (d, J1,2 = 7.9 Hz, 1H, H-1), 
4.59 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.54 (d, JCH2 = 11.3 Hz, 1H, 
0.5xCH2Bn), 4.44 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2Bn), 4.35 (d, J1,2 
= 7.9 Hz, 1H, H-1), 4.28 – 4.18 (m, 3H, H-4, H-6), 4.13 (d, J3,4 = 
3.6 Hz, 1H, H-4), 4.10 (dd, J2,3 = 10.3, J3,4 = 3.4 Hz, 1H, H-3), 4.05 
(d, J3,4 = 3.7 Hz, 1H, H-4), 3.95 (m, 1H, H-6), 3.90 (dd, J2,3 = 10.3, 
J3,4 = 3.4 Hz, 1H, H-3), 3.83 (t, J6a,6b = J5,6a = 9.8 Hz, 1H, H-6a), 
3.66 (dd, J6a,6b = 9.8, J5,6b = 5.4 Hz, 1H, H-6b), 3.53 – 3.44 (m, 1H, 
H-5), 3.29 (m, 1H, H-5), 3.19 (m, 1H, H-5), 1.86 (s, 3H, CH3Ac), 
1.00 (s, 9H, 3xCH3Piv), 1.00 (s, 12H, 3xCH3Piv), 0.98 (s, 9H, 
3xCH3Piv), 0.91 (s, 9H, 3xCH3TBDPS). 13C NMR (101 MHz, CDCl3) 
δ 177.3, 176.2, 176.1, 170.4, 138.3, 138.0, 137.8, 137.4, 135.62, 
135.55, 133.0-126.2 (30C), 100.4, 100.2, 100.2, 100.0, 99.5, 77.4, 
75.8, 75.7, 75.4, 74.8, 74.4, 73.9, 71.80, 71.77, 71.65, 70.8, 70.0, 
69.4, 68.9, 68.8, 67.4, 67.1, 61.4, 38.8, 38.7, 38.6, 27.3 (3C), 27.2 
(3C), 27.13 (3C), 27.05 (3C), 20.9, 19.3. HRMS (ESI-TOF) m/z: 
[M + Na]+ Calcd for C79H96NaO20Si: 1415.6162; Found 1415.6163. 
Benzyl 4-O-benzyl-2-O-pivaloyl-6-O-(tert-butyldiphenylsilyl)-
β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-
β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-
β-D-galactopyranoside (19b). Compound 18b (1.0 g; 0.72 mmol) 
was dissolved in dry CH2Cl2 (25 mL) and cooled to 0 °C. A 1 M L-
selectride solution in THF (1.5 mL) was added and the reaction was 
stirred at 0 °C until complete consumption of the starting material 
(4 h). The reaction mixture was poured into sat. aq. NH4Cl 
(100 mL). The organic phase was dried over MgSO4, filtered and 
concentrated (avoid concentrating to dryness since the borane salts 
can be explosive). The crude product was purified by flash chro-
matography to give an off-white solid. Yield: 0.84 g (88%). 
1H NMR (400 MHz, CDCl3) δ 7.57 (m, 4H, Ar-H), 7.49 – 7.07 (m, 
32H, Ar-H), 5.48 (s, 1H, Hbenzylidene), 5.43 (dd, J2,3 = 10.4, J1,2 = 7.6 
Hz, 1H) 5.40 (s, 1H, Hbenzylidene), 5.26 (dd, J2,3 = 10.2, J1,2 = 7.8 Hz, 
1H, H-1), 4.83 (d, JCH2 = 11.8 Hz, 1H, 0.5xCH2Bn), 4.80 – 4.72 (m, 
1H, H-2), 4.75 (d, J1,2 = 7.6 Hz, 1H, H-1), 4.67 (d, JCH2 = 11.4 Hz, 
1H, 0.5xCH2Bn), 4.47 (d, JCH2 = 11.8 Hz, 1H, 0.5xCH2Bn), 4.38 (d, 
J1,2 = 8.0 Hz, 1H, H-1), 4.36 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2Bn), 
4.25 (d, J3,4 = 3.2 Hz, 1H, H-4), 4.21 (d, J6a,6b = 11.5 Hz, 1H, H-6a), 
4.31 – 4.10 (m, 4H, H-11, 2xH-4, H-6b), 3.98 (d, J6a,6b = 12.4 Hz, 
1H, H-6a), 3.89 – 3.78 (m, 4H, H-3, H-5, H-6b), 3.72 (m, 1H, H-
6a), 3.66 – 3.59 (m, 1H, H-6b), 3.56 – 3.43 (m, 2H, 2xH-3), 3.30 
(s, 1H, H-5), 3.18 (s, 1H, H-5), 1.15 (s, 9H, 3xCH3Piv), 1.09 (s, 9H, 
3xCH3Piv), 1.06 (s, 9H, 3xCH3Piv), 0.97 (s, 9H, 3xCH3TBDPS). 13C 
NMR (101 MHz, CDCl3) δ 178.4, 178.3, 176.2, 138.1, 137.9, 
137.8, 137.4, 135.7 (2C), 135.6 (2C), 133.4, 133.1, 130.0-126.4 
(26C), 105.7, 100.9, 100.5, 100.3, 99.6, 78.4, 76.2, 75.9, 75.4, 75.2 
(2C), 74.5, 72.3, 71.3, 70.5, 69.9, 69.4, 68.9, 68.8, 67.0 (2C), 62.5, 
39.2, 39.1, 38.8, 27.4 (3C), 27.3 (3C), 27.1 (3C), 27.0 (3C), 19.3. 
HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for C77H94NaO19Si: 
1373.6056; Found 1373.6061. 
Phenyl 3-O-acetyl-6-O-allyl-4-O-benzyl-2-O-pivaloyl-1-thio-β-
D-galactopyranoside (17d). To a solution of Pd2(dba)3 (328 mg; 
0.36 mmol) and 1,4-Bis(diphenyl-phosphino)butane (611 mg; 
1.43 mmol) in dry THF (20 mL) was added the alcohol 13 (1.75 g; 
3.6 mmol) and allyl ethyl carbonate (1.86 g; 14.32 mmol) in dry 
THF (20 mL). The solution was stirred at 65 °C for 4 h, the solvent 
was evaporated and the crude product was purified by flash chro-
matographed (30:1 Tol/EtOAc) to give the pure O-allylated com-
pound 17d. Rf 0.60 (9:1 Tol/EtOAc). Yield: 1.56 g (83%). IR (neat, 
cm-1): 3061.43, 3031.49, 2973.33, 2933.85, 2907.2, 2871.32, 
1744.39, 1496.49, 1479.33, 1456.24, 1397.69, 1366.21, 1276.47, 
1232.00, 1145.02, 1078.08 ,1047.78, 918.76 1H NMR (400 MHz, 
CDCl3) δ 7.46 – 7.35 (m, 2H, Ar-H), 7.35 – 7.13 (m, 8H, Ar-H), 
5.78 (ddt, Jtrans = 17.2, Jcis = 10.8, JCH2 = 5.6 Hz, 1H, -CH=CH2), 
5.34 (t, J1,2 = J2,3 =10.0 Hz, 1H, H-2), 5.17 (dd, Jtrans = 17.2, JCH2 = 
1.7 Hz, 1H, CH2=CHtrans), 5.10 (dt, Jcis = 10.4, JCH2 = 1.7 Hz, 1H, 
CH2=CHcis), 5.00 (dd, J2,3 = 10.0, J3,4 = 3.0 Hz, 1H, H-3), 4.65 (d, 
J = 11.6 Hz, 1H, 0.5xCH2Bn), 4.63 (d, J1,2 = 10.0 Hz, 1H, H-1), 4.50 
(d, JCH2 = 11.6 Hz, 1H, 0.5xCH2Bn), 3.93 (dd, J3,4 = 3.1, J4,5 = 0.9 
Hz, 1H, H-4), 3.89 (ddt, JCH2a,CH2b= 12.8, JCH=CH2, CH2= 5.6, JCH2=CH, 
CH2 = 1.7 Hz, 1H, CH2=CH), 3.82 (ddt, JCH2a,CH2b = 12.7, JCH=CH2, 
CH2=5.6, JCH2=CH, CH2=1.7 Hz, 1H, CH2=CH), 3.68 (ddd, J5,6a = 6.9, 
J5,6b = 5.8, J4,5 =1.0 Hz, 1H, H-5), 3.60 – 3.46 (m, 1H, H-6a, H-6b), 
1.87 (s, 3H, CH3Ac), 1.13 (s, 9H, 3xCH3Piv). 13C NMR (101 MHz, 
CDCl3) δ 176.8, 170.3, 138.1, 134.4, 133.6, 132.2 (2C), 129.0 (2C), 
 128.5 (2C), 128.2 (2C), 127.9, 127.8, 117.4, 87.1, 77.4, 75.0, 74.9, 
74.4, 72.5, 68.2, 67.7, 38.9, 27.2 (3C), 20.9. HRMS (ESI-TOF) 
m/z: [M + Na]+ Calcd for C29H36NaO7S: 551.2079; Found 
551.2082. 
Benzyl 3-O-acetyl-6-O-allyl-4-O-benzyl-2-O-pivaloyl-β-D-ga-
lactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-ga-
lactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-ga-
lactopyranoside (18d). To a 25 mL flame-dried flask was added 
16 (900 mg, 1.16 mmol) and 17d (918 mg, 1.74 mmol). The mix-
ture was dried azeotropically with toluene (2x10 mL) and subjected 
to vacuum overnight. It was then dissolved in dry CH2Cl2 (5 mL) 
and dry MeCN (5 mL), cooled to -30 °C, followed by addition of 
NIS (442 mg; 1.97 mmol) and TESOTf (61 mg; 0.23 mmol). The 
reaction mixture was stirred at -30 °C until TLC revealed full con-
version of the donor (2 h). The solution was diluted with CH2Cl2 
(100 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. 
NaHCO3 (100 mL). The organic phase was dried over MgSO4, fil-
tered and concentrated. The product was purified by flash chroma-
tography to afford as a slightly yellow solid. Yield: 707 mg (51%). 
1H NMR (400 MHz, CDCl3) δ 7.57 – 7.46 (m, 4H, Ar-H), 7.39 – 
7.22 (m, 16H, Ar-H), 5.83 (ddt, Jtrans = 17.2, Jcis = 10.3, JCH2 = 5.9 
Hz, 1H, -CH=CH2), 5.55 (s, 1H, CHbenzylidene), 5.54 (s, 1H, CHben-
zylidene), 5.45 (dd, J2,3 = 10.0, J1,2 = 7.9 Hz, 1H, H-2), 5.41 (dd, J2,3 = 
10.3, J1,2 = 8.0 Hz, 1H, H-2), 5.36 (dd, J2,3 = 10.1, J1,2 = 7.9 Hz, 1H, 
H-2), 5.23 (dq, Jtrans = 17.2, , JCH2 = 1.5 Hz, 1H, CH2=CH-), 5.17 
(dd, Jcis = 10.3, JCH2 =1.5 Hz, 1H, CH2=CH-), 4.90 (d, JCH2 = 12.0 
Hz, 1H, CH2Bn), 4.86 (dd, J2,3 = 10.1, J3,4 = 3.1 Hz, 1H, H-3), 4.80 
(d, JCH2 = 11.3 Hz, 1H, CH2Bn), 4.77 (d, J1,2 = 7.9 Hz, 1H, H-1), 
4.63 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.54 (d, JCH2 = 11.9 Hz, 1H, CH2Bn), 
4.45 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.44 (d, JCH2 = 11.3 Hz, 1H, CH2Bn), 
4.36 – 4.29 (m, 3H, H-4, H-6), 4.25 (d, J3,4 = 3.3 Hz, 1H, H-4), 4.24 
(dd, J2,3 = 10.1, J3,4 = 3.3 Hz, 1H, H-3), 4.08 – 4.02 (m, 2H, H-6), 
3.97 (d, J3,4 = 3.1 Hz, 1H, H-4), 3.92 (dd, J5,6a = 4.9, J5,6b = 1.3 Hz, 
1H, H-5), 3.88 (tt, JCH = 5.9, JCH2 = 1.5 Hz, 2H, CH2Allyl), 3.81 (dd, 
J2,3 = 10.1, J3,4 = 3.3 Hz, 1H, H-3), 3.65 (t, J = 6.5 Hz, 1H, H-5), 
3.56 – 3.44 (m, 2H, H-6), 3.39 (s, 1H, H-5), 3.35 (s, 1H, H-5), 1.96 
(s, 3H, CH3Ac), 1.17 (s, 9H, 3xCH3Piv), 1.15 (s, 9H, 3xCH3Piv), 1.13 
(s, 9H, 3xCH3Piv). HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for 
C64H80NaO19 1175.5294; Found 1175.5154. 
Benzyl 6-O-allyl-4-O-benzyl-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
noside (19d). Compound 18d (200 mg; 0.17 mmol) was dissolved 
in dry CH2Cl2 (10 mL) and cooled to 0 °C. A 1 M L-selectride so-
lution in THF (0.7 mL) was added and the reaction was stirred at 0 
°C until complete consumption of the starting material (3 h). The 
reaction mixture was poured into sat. aq. NH4Cl (100 mL). The or-
ganic phase was dried over MgSO4, filtered and concentrated 
(avoid concentrating to dryness since the borane salts can be explo-
sive). The crude product was purified by flash chromatography to 
give a foamy white product. Yield: 191 mg (92%). 1H NMR (400 
MHz, CDCl3) δ 7.59 – 7.45 (m, 4H, Ar-H), 7.41 – 7.19 (m, 16H, 
Ar-H), 5.85 (ddt, Jtrans = 17.2, Jcis = 10.3, JCH2 = 5.9 Hz, 1H, -
CH=CH2), 5.57 (s, 1H, CHbenzylidene), 5.52 (s, 1H, CHbenzylidene), 5.52 
(dd, J2,3 = 10.1, J1,2 = 7.7 Hz, 1H, H-2), 5.35 (dd, J2,3 = 10.2, J1,2 = 
8.0 Hz, 1H, H-2), 5.23 (dq, Jtrans = 17.1, , JCH2 = 1.6 Hz, 1H, 
CH2=CH-), 5.17 (dd, Jcis = 10.3, JCH2 =1.4 Hz, 1H, CH2=CH-), 4.91 
(d, JCH2 = 11.9 Hz, 1H, CH2Bn), 4.87 (d, J1,2 = 8.1 Hz, 1H, H-1), 
4.82 (dd, J2,3 = 10.3, J3,4 = 3.1 Hz, 1H, H-3), 4.77 (d, JCH2 = 11.4 
Hz, 1H, CH2Bn), 4.56 (d, JCH2 = 11.9 Hz, 1H, CH2Bn), 4.47 (d, J1,2 = 
7.6 Hz, 1H, H-1), 4.44 (d, JCH2 = 11.3 Hz, 1H, CH2Bn), 4.36 – 4.26 
(m, 4H, H-2, H-4, H-4, H-6), 4.27 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.24 
(dd, J2,3 = 10.3, J3,4 = 3.4 Hz, 1H, H-3), 4.12 – 4.00 (m, 2H, H-4, H-
6), 3.95 – 3.85 (m, 3H, H-3, CH2Allyl) 3.71 – 3.42 (m, 3H, H-5, H-
6), 3.40 (s, 1H, H-5), 3.38 (s, 1H, H-5), 1.21 (s, 9H, 3xCH3Piv), 1.18 
(s, 9H, 3xCH3Piv), 1.12 (s, 9H, 3xCH3Piv). 13C NMR (101 MHz, 
CDCl3) δ 178.27, 176.23, 138.13, 137.92, 137.81, 137.37, 134.55, 
129.07, 128.76, 128.49, 128.41, 128.32, 128.27, 128.10, 128.04, 
127.99, 127.95, 127.64, 126.49, 126.36, 117.25, 105.45, 101.00, 
100.53, 100.39, 99.56, 78.22, 77.36, 76.21, 76.01, 75.17, 74.62, 
73.90, 72.44, 72.34, 71.17, 70.60, 69.95, 69.29, 68.94, 68.87, 
68.83, 67.11, 67.04, 39.17, 39.09, 38.84, 27.38, 27.29, 27.09. 
HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for C66H82NaO20 
1217.5292; Found 1217.5260. 
Phenyl 4,6-O-benzylidene-3-O-chloroacetyl-1-thio-β-D-galacto-
pyranoside (9b)45. Di-n-butyl tin oxide (21.8 g; 87.4 mmol) was 
added to a solution of compound 8 (30.0 g, 83.2 mmol) in dry tol-
uene (600 mL) and stirred under refluxing temperature for 12 h. 
The reaction mixture was cooled to 0 °C, and freshly activated 4Å 
MS (30 g) were added. After 30 min chloroacetyl chloride (6.7 mL, 
85.7 mmol) were added drop wise and stirring was maintained for 
1 h at 0 °C. The reaction was quenched by addition of MeOH, fil-
tered through a pad of celite and concentrated. The crude product 
was purified by flash chromatography (9:1 Tol/EtOAc) to give 9b 
as an off-white solid. Rf 0.16 (9:1 Tol/EtOAc). Yield: 33.1 g (91%). 
IR (neat, cm-1): 3481.62, 3090.41, 2951.69, 2870.27, 1756.92, 
1479.38, 1406.63, 1365.59, 1313.58, 1288.85, 1166.86, 1044.29, 
1025.82. 1H NMR (400 MHz, CDCl3) δ 7.65 –7.57 (m, 2H, Ar-H), 
7.34 – 7.26 (m, 8H, Ar-H), 5.40 (s, 1H, -CHbenzylidene), 4.90 (dd, J2,3 
= 9.6, J3,4 = 3.4 Hz, 1H, H-3), 4.51 (d, J1,2 = 9.6 Hz, 1H, H-1), 4.35 
(dd, J3,4 = 3.4, J4,5 = 1.1 Hz, 1H, H-4), 4.32 (dd, J6a,6b = 12.5, J5,6a = 
1.6 Hz, 1H, H-6a), 4.05 (d, JCH2 = 15.3 Hz, 1H, 0.5xCH2AcCl), 4.00 
(d, J = 15.3 Hz, 1H, 0.5xCH2AcCl), 3.96 (dd, J6a,6b = 12.5, J5,6b = 1.7 
Hz, 1H, H-6b), 3.90 (td, J1,2 = J2,3 = 9.6, J2,OH = 2.5 Hz, 1H, H-2), 
3.55 (m, 1H, H-5), 2.34 (d, J2,OH = 2.5 Hz, 1H, OH). 13C NMR 
(101 MHz, CDCl3) δ 167.2, 137.5, 133.7 (2C), 130.1, 129.2, 129.1 
(2C), 128.4, 128.2 (2C), 126.4 (2C), 101.0, 87.5, 76.5, 73.3, 69.8, 
69.1, 65.5, 40.9. HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for 
C21H21ClNaO6S 459.0645; Found 459.0639. 
Phenyl 4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-1-
thio-β-D-galactopyranoside (10b). Compound 9b (25 g; 57.2 
mmol) was dissolved in CH2Cl2 (400 mL). Et3N (16.0 mL; 114.4 
mmol), DMAP (3.5 g; 28.6 mmol) and pivaloyl chloride (7.3 mL; 
85.8 mmol) was added to the solution and the reaction mixture was 
heated to 45 °C for 4 h. The reaction mixture was cooled to 0 °C, 
quenched with MeOH (10 mL), washed with water (2x400 mL), 
dried over MgSO4 and concentrated. The product was purified by 
flash chromatography (15:1 Tol/EtOAc) to afford 10b as a white 
powder. Rf 0.44 (9:1 Tol/EtOAc). Yield 26.2 g (88%). IR (neat, 
cm-1): 3061.25, 3036.54, 2974.08, 2935.25, 2905.99, 2871.97, 
1764.64, 1733.56, 1479.53, 1457.77, 1402.52, 1366.86, 1312.92, 
1281.38, 1249.15, 1147.33, 1092.80, 1048.41, 1025.97, 997.24. 1H 
NMR (400 MHz, CDCl3) δ 7.56 – 7.47 (m, 2H, Ar-H), 7.35 – 7.25 
(m, 8H, Ar-H), 5.40 (s, 1H, CHbenzylidene), 5.28 (t, J1,2 = J2,3 = 9.9 Hz, 
1H, H-2), 5.07 (dd, J2,3 = 9.9, J3,4 = 3.5 Hz, 1H, H-3), 4.67 (d, J1,2 = 
9.9 Hz, 1H, H-1), 4.31 (dd, J6a,6b = 11.5, J5,6a = 0.9 Hz, 1H, H-6a), 
4.30 (d, J = 3.5 Hz, 1H, H-4), 3.96 (dd, J6a,6b = 11.5, J5,6b = 1.8 Hz, 
1H, H-6b), 3.95 (d, JCH2 = 15.2 Hz, 1H, CH2AcCl), 3.87 (d, JCH2 = 
15.2 Hz, 1H, CH2AcCl), 3.53 (s, 1H, H-5), 1.14 (s, 9H, 3xCH3Piv). 
13C NMR (101 MHz, CDCl3) δ 176.5, 167.1, 137.4, 133.8 (2C), 
131.4, 129.4, 128.9 (2C), 128.4, 128.3 (2C), 126.6 (2C), 101.2, 
85.4, 74.8, 73.5, 69.7, 69.2, 66.2, 40.7, 38.9, 27.2 (3C). HRMS 
(ESI-TOF) m/z: [M + NH4]+ Calcd for C26H33ClNO7S 538.1666 
Found 538.1671. 
4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-D-galactopy-
ranose (11b). Compound 10b (20.0 g; 38.4 mmol) was dissolved 
in acetone (180 mL) and water (20 mL). NBS (27.3 g; 153.5 mmol) 
and 2,4-lutidine (22.2 mL; 107.2 mmol) were added and the reac-
tion was stirred at 50 °C until TLC showed full conversion (3h). 
 The solution was diluted with CH2Cl2 (500 mL) and washed with 
sat. aq. NaS2O3 (200 mL) and sat. aq. NaHCO3 (200 mL). The or-
ganic phase was dried over MgSO4, filtered and concentrated. The 
product was purified by flash chromatography (6:1 toluene/EtOAc) 
to afford 11b as an α/β mixture. Rf 0.13 (9:1 toluene/EtOAc). Yield: 
12.5 g (76%). IR (neat, cm-1):3063.99, 3030.86, 2972.24, 2931.14, 
2870.06, 1738.21, 1479.47, 1454.40, 1365.98, 1277.87, 1150.65, 
1134.03, 1101.35, 1064.79. 1H NMR (400 MHz, CDCl3) δ 7.49 – 
7.03 (m, 10H, Ar-H), 5.51 (d, J1,2 = 3.5 Hz, 1H, H-1α), 5.45 (dd, 
J2,3 = 10.1, J3,4 = 2.9 Hz, 1H, H-3α), 5.43 (s, 1H, Hbenzylideneβ), 5.41 
(s, 1H, Hbenzylideneα), 5.18 (dd, J2,3 =10.1, J1,2 = 3.5 Hz, 1H, H-2α), 
5.13 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2β), 5.02 (dd, J2,3 =10.4, 
J3,4 = 3.6 Hz, 1H, H-3β), 4.60 (d, J1,2 = 7.9 Hz, 1H, H-1β), 4.32 (dd, 
J3,4 = 2.9, J4,5 = 1.1 Hz, 1H, H-4α), 4.29 – 4.22 (m, 1H, H-4b, H-
6a,β) 4.16 (dd, J6a,6b = 12.6, J5,6a = 1.5 Hz, 1H, H-6a,α), 4.01 (d, 
JCH2 = 15.0 Hz, 1H, 0.5xCH2AcCl), 3.94 (m, 3H, H-6b,α;H-6b,β; 
0.5xCH2AcCl), 3.91 (m, 2H, H-5α, H-5β), 1.11 (m, 18H, 6xCH3Piv). 
13C NMR (101 MHz, CDCl3) δ 177.7, 176.9, 165.9, 136.8, 136.4, 
136.2, 128.2, 128.1, 128.0, 127.3, 127.22, 127.19, 125.2, 125.1, 
124.3, 99.7, 99.6, 94.8, 89.8, 72.9, 72.2, 71.9, 69.5, 69.0, 68.1, 67.9, 
67.2, 65.4, 60.9, 39.7, 39.5, 37.9, 37.8, 25.9. HRMS (ESI-TOF) 
m/z: [M + NH4]+ Calcd for C20H30ClNO8 447.1660 Found 
447.1671. 
4,6-O-Benzylidene-3-O-chloroacetyl-2-O-pivaloyl-1-thio-β-D-
galactopyranose N-phenyl trifluoroacetimidate (12b). Com-
pound 11b (10 g; 23.3 mmol) was dissolved in CH2Cl2 (230 mL) 
and cooled to 0 °C. Cs2CO3 (15.2 g; 46.6 mmol) was added fol-
lowed by N-phenyl trifluoroacetimidoyl chloride (9.7 g; 46.6 
mmol). The ice bath was removed and the reaction mixture was 
stirred until TLC showed full conversion (5 h). It was then filtered, 
concentrated and purified by flash chromatography to give an off-
white foam. Yield: 11.2 g (80%). 
Phenyl 4,6-O-benzylidene-2-O-pivaloyl-1-thio-β-D-galactopy-
ranoside (14). Compound 10b (10 g; 19.2 mmol) was dissolved in 
dry CH2Cl2 (190 mL) and cooled to 0 °C. A 1 M L-selectride solu-
tion in THF (57.6 mL) was added and the reaction was stirred at 0 
°C until complete consumption of the starting material (1 h). The 
reaction mixture was poured into sat. aq. NH4Cl (400 mL). The or-
ganic phase was dried over MgSO4, filtered and concentrated 
(avoid concentrating to dryness since the borane salts can be explo-
sive). The crude product was purified by flash chromatography to 
give 14 as a white solid. Yield: 8.2 g (96%). 1H NMR (400 MHz, 
CDCl3) δ 7.51 (m, 2H, Ar-H), 7.38 – 7.10 (m, 10H, Ar-H), 5.45 (s, 
1H, CHbenzylidene), 4.98 (t, J1,2 = J2,3 = 9.7 Hz, 1H, H-2), 4.60 (d, J1,2 
= 9.7 Hz, 1H, H-1), 4.31 (dd, J6a,6b = 12.5, J5,6a =1.5 Hz, 1H, H-6a), 
4.14 (dd, J3,4 = 3.6, J4,5 =1.1 Hz, 1H, H-4), 3.96 (dd, J6a,6b = 12.5, 
J5,6b = 1.7 Hz, 1H, H-6b), 3.67 (dd, J2,3 = 9.7, J3,4 = 3.6 Hz, 1H, H-
3), 3.51 – 3.43 (m, 1H, H-5), 1.19 (s, 9H, 3xCH3Piv). 13C NMR (101 
MHz, CDCl3) δ 177.6, 137.4, 133.6 (2C), 131.6, 129.4, 128.8 (2C), 
128.2 (2C), 128.1, 126.5 (2C), 101.4, 85.1, 75.7, 72.9, 69.9, 69.5, 
69.2, 38.8, 27.2 (3C). HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for 
C24H28NaO6S: 467.1504; Found 467.1511. 
Phenyl 4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-1-
thio-β-D-galactopyranoside (15b). To a 250 mL flame-dried flask 
was added 14 (6.5 g, 14.6 mmol) and the 12b (11.4 g, 19.0 mmol). 
The mixture was co-evaporated with toluene (2x150 mL) and sub-
jected to vacuum overnight. The mixture dissolved in CH2Cl2 
(150 mL) and cooled to -40 °C. TMSOTf (0.22 mL; 1.5 mmol) was 
added and the reaction mixture was stirred at -40 °C for 2 h. Et3N 
(1 mL) was added and the reaction mixture was concentrated. The 
crude compound was purified by flash chromatography (9:1 
Tol/EtOAc) affording 15b. Rf 0.26 (9:1 Tol/EtOAc). Yield: 10.5 g 
(84%). 1H NMR (400 MHz, CDCl3) δ 7.51 – 7.36 (m, 5H), 7.35 – 
7.22 (m, 6H), 7.17 – 7.04 (m, 3H), 5.49 (s, 1H, -CHbenzylidene), 5.43 
(s, 1H, -CHbenzylidene), 5.33 (dd, J2,3 = 9.7 J1,2 = 8.1 Hz, 1H, H-2’), 
5.30 (t, J1,2 = J2,3 = 9.7 Hz, 1H, H-2), 4.87 (d, J = 8.1 Hz, 1H, H-1’), 
4.86 (d, J = 3.8 Hz, 1H), 4.60 (d, J1,2 = 9.7 Hz, 1H, H-1), 4.34 – 
4.17 (m, 4H, H-3, H-4, H-4’, H-6a’), 4.00 (dd, J = 12.5, 1.5 Hz, 1H, 
H-6a), 3.99 (d, JCH2 = 15.3 Hz, 1H, CH2AcCl), 3.98 – 3.89 (dd, J6a,6b 
= 12.5 Hz, J5,6b =1.5, 1H, H-6b), 3.93 (dd, J6a,6b = 12.3 Hz, J5,6b 
=1.1, 1H, H-6b’), 3.91 (d, JCH2 = 15.2 Hz, 1H, CH2AcCl), 3.38 (m, 
2H, H-5, H-5’), 1.22 (s, 9H, -CH3Piv), 1.00 (s, 9H, -CH3Piv). 13C 
NMR (101 MHz, CDCl3) δ 176.9, 176.1, 167.1, 137.8, 137.3, 
133.4, 132.3 (2C), 129.2, 128.7 (2C), 128.6, 128.3 (2C), 127.9 
(2C), 127.6, 126.22 (2C), 126.19 (2C), 100.9, 100.2, 99.3, 86.8, 
75.9, 73.6, 73.5, 73.3, 70.2, 69.5, 68.9, 68.7, 68.2, 66.6, 40.6, 38.79, 
38.76, 27.4 (3C), 27.0 (3C). HRMS (ESI-TOF) m/z: [M + NH4]+ 
Calcd for C44H55ClNO13S 872.3083 Found 872.3092. 
Phenyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-1-thio-β-D-galac-
topyranoside (20). Compound 15b (1.8 g; 2.1 mmol) was dis-
solved in dry CH2Cl2 (40 mL) and cooled to 0 °C. A 1 M L-selec-
tride solution in THF (5.3 mL) was added and the reaction was 
stirred at 0 °C until complete consumption of the starting material 
was observed (30 min). The reaction mixture was quenched with 
sat. aq. NH4Cl (50 mL). The organic phase was dried over MgSO4, 
filtered and concentrated (avoid concentrating to dryness since the 
borane salts can be explosive). The residue was filtered through a 
plug of silica (9:1 Tol/EtOAc). The semi-crude alcohol (1.4 g; 1.8 
mmol) was dissolved in CH2Cl2 (20 mL). Et3N (0.5 mL; 3.6 mmol), 
DMAP (0.1 g; 0.9 mmol) and pivaloyl chloride (0.4 mL; 3.6 mmol) 
was added to the solution and the reaction mixture was heated to 
45 °C for 4 h. The reaction mixture was cooled to 0 °C, quenched 
with MeOH (0.5 mL), washed with water (2x50 mL), dried over 
MgSO4 and concentrated. The product was purified by flash chro-
matography (Tol/EtOAc 9:1) to afford 20 as an off-white solid. Rf 
0.26 (9:1 Tol/EtOAc). Yield 1.3 g (80% over two steps). IR (neat, 
cm-1): 3065.46, 2933.04, 1734.90, 1479.30, 1455.98, 1397.64, 
1366.82, 1279.26, 1173.33, 1140.59, 1091.22, 1048.23, 1026.27. 
1H NMR (400 MHz, CDCl3) δ 7.49 –7.34 (m, 6H, Ar-H), 7.26 (m, 
9H, Ar-H), 5.47 (s, 1H, -CHbenzylidene), 5.45 (s, 1H, -CHbenzylidene), 
5.37 (dd, J2,3 = 10.5, J1,2 = 8.0 Hz, 1H, H-2’), 5.29 (t, J1,2 = J2,3 = 9.8 
Hz, 1H, H-2), 4.81 (d, J1,2 = 8.0 Hz, 1H, H-1’), 4.69 (dd, J2,3 = 10.5, 
J3,4 = 3.7 Hz, 1H, H-3’), 4.60 (d, J1,2 = 9.8 Hz, 1H, H-1), 4.38 – 4.17 
(m, 5H, H-3, H-4, H-4’, H-6a, H-6a’), 4.01 (dd, J6a,6b = 12.5, J5,6b 
=1.8 Hz, 1H, H-6b’), 3.93 (dd, J6a,6b = 12.4, J5,6b =1.6 Hz, 1H, H-
6b), 3.42 – 3.34 (m, 2H, H-5, H-5’), 1.22 (s, 9H, 3xCH3Piv), 1.07 (s, 
9H, 3xCH3Piv), 0.98 (s, 9H, 3xCH3Piv). 13C NMR (101 MHz, 
CDCl3) δ 178.2, 176.8, 176.1, 137.9, 137.5, 133.4, 132.3 (2C), 
128.9, 128.7 (2C), 128.5, 128.2 (2C), 127.9 (2C), 127.5, 126.2 
(2C), 125.9 (2C), 100.4, 100.1, 99.3, 86.7, 75.8, 73.1 (2C), 71.9, 
70.2, 69.7, 68.9, 68.8, 68.2, 66.8, 38.9, 38.8, 38.7, 27.4, 27.00, 
26.98. HRMS (ESI-TOF) m/z: [M+Na]+ Calcd for C47H58NaO13S 
885.3496; Found 885.3499. 
Phenyl 6-O-acetyl-4-O-benzyl-3-O-chloroacetyl-2-O-pivaloyl-
1-thio-β-D-galactopyranoside (21). A solution of 1 M BH3 in THF 
(76.7 mL) was added to a 250 ml dry flask containing 10b (4.0 g; 
7.7 mmol) at 0 °C and the solution was stirred for 5 minutes. A 
solution of 1 M Cu(OTf)2 in CH2Cl2 (8.1 mL) was then added to the 
clear solution slowly. After 1.5 hours at 0 °C, TLC showed full 
consumption of starting material. Triethylamine (2 mL) was added 
followed by careful addition of methanol until the evolution of H2 
had ceased. The reaction mixture was co-distilled with methanol 
three times and the crude was used in the next step. The crude ma-
terial was dissolved in CH2Cl2 (50 mL). Et3N (1.1 mL; 7.7 mmol), 
DMAP (0.01 g; 0.1 mmol) and acetic anhydride (0.61 mL; 
6.5 mmol) was added to the solution and the reaction mixture was 
 stirred until TLC revealed full conversion (1 h). The reaction was 
quenched with MeOH (1 mL), diluted with CH2Cl2 (50 mL), 
washed with water (2x100 mL), dried over MgSO4 and concen-
trated. The product was purified by flash chromatography 
(Tol/EtOAc 15:1) to afford 21 as an off-white solid. Rf 0.42 (9:1 
Tol/EtOAc). Yield: 2.8 g (68%) over two steps. IR (neat, cm-1): 
3061.37, 3031.47, 2972.29, 2906.59, 2872.68, 1739.50, 1584.17, 
1496.32, 1479.63, 1455.92, 1440.05, 1398.67, 1369.01, 1277.91, 
1232.53, 1172.17, 1139.11, 1088.80, 1043.02. 1H NMR 
(400 MHz, CDCl3) δ 7.47 – 7.37 (m, 2H), 7.33 – 7.15 (m, 8H), 5.34 
(t, J1,2 = J2,3 = 9.9 Hz, 1H, H-2), 5.06 (dd, J2,3 = 9.9, J3,4 = 3.0 Hz, 
1H, H-3), 4.62 (d, J1,2 = 9.9 Hz, 1H, H-1), 4.63 (d, JCH2 = 11.9 Hz, 
1H, CH2Bn), 4.53 (d, JCH2 = 11.9 Hz, 1H, CH2Bn), 4.26 (dd, J6a,6b = 
11.2, J5,6a = 6.7 Hz, 1H, H-6a), 4.04 (dd, J6a,6b = 11.2, J5,6b = 6.2 Hz, 
1H, H-6b), 3.88 (dd, J3,4 = 3.0, J4,5 = 1.0 Hz, 1H, H-4), 3.80 (d, J = 
14.9 Hz, 1H, 0.5xCH2AcCl), 3.74 (d, J = 15.0 Hz, 1H, 0.5xCH2AcCl), 
3.72 – 3.67 (m, 1H, H-5), 1.95 (s, 3H, -CH3Ac), 1.13 (s, 9H, 
3xCH3Piv). 13C NMR (101 MHz, CDCl3) δ 176.8, 170.5, 166.8, 
137.4, 133.0, 132.6 (2C), 129.0 (2C), 128.6 (2C), 128.4 (2C), 
128.2, 128.1, 86.9, 76.5, 76.0, 75.1, 73.9, 67.4, 62.5, 40.4, 38.9, 
27.2 (3C), 20.9. HRMS (ESI-TOF) m/z: [M+Na]+ Calcd for 
C28H33ClNaO8S 587.1482; Found 587.1481. 
Benzyl 6-O-acetyl-4-O-benzyl-3-O-chloroacetyl-2-O-pivaloyl-
β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-
β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-
β-D-galactopyranoside (22). To a 25 mL flame-dried flask was 
added 16 (3.0 g, 3.9 mmol) and the 21 (1.5 g, 1.8 mmol). The mix-
ture was dried azeotropically with toluene (2x10 mL) and subjected 
to vacuum overnight. It was then dissolved in dry CH2Cl2 (5 mL) 
and dry MeCN (5 mL), cooled to – 30 °C, followed by addition of 
NIS (420 mg; 1.9 mmol) and TESOTf (56 mg; 0.2 mmol). The re-
action mixture was stirred at -30 °C until TLC revealed full con-
version of the donor (2 h). The solution was diluted with CH2Cl2 
(100 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. 
NaHCO3 (100 mL). The organic phase was dried over MgSO4, fil-
tered and concentrated. The product was purified by flash chroma-
tography (6:1 Tol/EtOAc) to afford an off-white solid. Rf 0.60 (2:1 
Tol/EtOAc). Yield: 3.6 g (75%). 1H NMR (400 MHz, CDCl3) δ 
7.49 – 7.15 (m, 20H, Ar-H), 5.48 (s, 1H, CHbenzylidene), 5.47 (s, 1H, 
CHbenzylidene), 5.37 (dd, J2,3 = 10.2, J1,2 = 7.9 Hz, 1H, H-21), 5.31 (dd, 
J2,3 = 10.3, J1,2 = 8.0 Hz, 1H, H-23), 5.27 (dd, J2,3 = 10.2, J1,2 = 7.7 
Hz, 1H, H-22), 4.88 (dd, J2,3 = 10.3, J3,4 = 3.0 Hz, 1H, H-33), 4.82 
(d, JCH2 = 11.9 Hz, 1H, 0.5xCH2Bn), 4.73 (d, J1,2 = 7.7 Hz, 1H, H-
12), 4.70 (d, J1,2 = 8.0 Hz, 1H, H-13), 4.63 (d, JCH2 = 11.7 Hz, 1H, 
0.5xCH2Bn), 4.51 (d, JCH2 = 11.7 Hz, 1H, 0.5xCH2Bn), 4.45 (d, JCH2 
= 11.9 Hz, 1H, 0.5xCH2Bn), 4.36 (d, J1,2 = 7.9 Hz, 1H, H-11), 4.32 
– 3.94 (m, 12H, H-31, H-32, H-41, H-42, 3xH-6), 3.86 (d, J = 3.0 
Hz, 1H, H-43), 3.79 (d, JCH2 = 15.0 Hz, 1H, CH2AcCl), 3.72 (d, JCH2 
= 15.0 Hz, 1H, CH2AcCl), 3.60 (t, J5,6a = J5,6b = 6.6 Hz, 1H, H-53), 
3.31 (s, 1H, H-51/2), 3.29 (s, 1H, H-51/2), 1.95 (s, 3H, CH3Ac), 1.09 
(s, 9H, CH3Piv), 1.05 (s, 9H, CH3Piv), 1.00 (s, 9H, CH3Piv).13C NMR 
(101 MHz, CDCl3) δ 177.2, 176.11, 176.10, 170.3, 166.84, 138.0, 
137.8, 137.32, 137.30, 128.8-126.1 (20C), 100.4, 100.3 (2C), 99.9, 
99.7, 75.83, 75.77, 75.2, 75.0, 73.6, 72.6 (2C), 71.9, 71.8, 71.1, 
70.0, 69.0, 68.9, 68.8, 67.4, 67.0, 62.0, 40.4, 38.9, 38.8, 38.7, 27.31 
(3C), 27.25 (3C), 27.1 (3C), 20.9. HRMS (ESI-TOF) m/z: 
[M+NH4]+ Calcd for C64H81ClNO20 1250.4761 Found 1250.4763. 
Benzyl 6-O-acetyl-4-O-benzyl-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
noside (23). Compound 22 (1.6 g; 1.3 mmol) was dissolved in 25 
mL dry THF. Thiourea (382 mg; 5.0 mmol), Bu4NI (93 mg; 0.25 
mmol) and NaHCO3 (464 mg; 5.5 mmol) was added and the reac-
tion mixture was heated to 55 °C for 12 h. The mixture was filtered, 
concentrated and purified by flash chromatography (4:1 
Tol/EtOAc) to give 23 as a yellowish amorphous material. Rf 0.49 
(2:1 Tol/EtOAc). Yield: 1.2 g (82%). IR (neat, cm-1):3521.34, 
2973.04, 2932.85, 2907.14, 2872.47, 1737.38, 1479.63, 1454.83, 
1397.45, 1366.55, 1277.19, 1231.25, 1133.51, 1078.77, 1061.55, 
1044.64. 1H NMR (400 MHz, CDCl3) δ 7.50 – 7.14 (m, 20H), 5.49 
(s, 1H, CHbenzylidene), 5.45 (s, 1H, CHbenzylidene), 5.39 (dd, J2,3 = 10.2, 
J1,2 = 7.9 Hz, 1H, H-21), 5.36 (dd, J2,3 = 10.4, J1,2 = 8.0 Hz, 1H, H-
22), 4.85 (dd, J2,3 = 10.0, J1,2 = 7.7 Hz, 1H, H-23), 4.83 (d, JCH2 = 
11.9Hz, 1H, 0.5xCH2Bn), 4.76 (d, JCH2 = 11.5 Hz, 1H, 0.5xCH2Bn), 
4.70 (d, J1,2 = 8.0 Hz, 1H, H-12), 4.65 (d, J1,2 = 7.7 Hz, 1H, H-13), 
4.61 (d, JCH2 = 11.5 Hz, 1H, 0.5xCH2Bn), 4.45 (d, JCH2 = 11.9 Hz, 
1H, 0.5xCH2Bn), 4.37 (d, J1,2 = 7.9 Hz, 1H, H-11), 4.33 – 4.13 (m, 
6H, H-31, 2xH-4, 1.5xH-6), 4.01 (m, 3H, 1.5xH-6), 3.93 (dd, J2,3 = 
10.4, J3,4 = 3.4 Hz, 1H, H-32), 3.71 (d, J3,4 = 2.5 Hz, 1H, H-43), 3.55 
– 3.46 (m, 2H, H-33, H-53), 3.32 (s, 1H, H-5), 3.30 (s, 1H, H-5), 
1.94 (s, 3H, CH3Ac), 1.09 (s, 9H, 3xCH3Piv), 1.06 (s, 9H, 3xCH3Piv), 
1.05 (s, 9H, 3xCH3Piv). 13C NMR (101 MHz, CDCl3) δ 180.4, 
176.11, 176.05, 170.4, 138.0, 137.8, 137.7, 137.3, 129.9-126.1 
(20C), 100.4 (2C), 100.3, 99.9, 99.7, 76.2, 76.0, 75.9, 75.83, 75.79, 
74.0, 73.7, 72.7, 72.6, 71.9, 71.8, 71.1, 70.0, 68.9, 68.8, 67.4, 67.1, 
62.5, 39.1, 38.8, 38.7, 27.3 (3C), 27.3 (3C), 27.1 (3C) 20.9. HRMS 
(ESI-TOF) m/z: [M + NH4] + Calcd for C63H82NO20 1172.5430 
Found 1172.5440. 
Benzyl 4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-6-O-acetyl-4-O-benzyl-2-O-pivaloyl-
β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-
β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-
β-D-galactopyranoside (24). To a 25 mL flame-dried flask was 
added 23 (1.2 g, 1.0 mmol) and the 15b (1.2 g, 1.4 mmol). The 
mixture was dried azeotropically with toluene (2x10 mL) and sub-
jected to vacuum overnight. It was then dissolved in dry CH2Cl2 (5 
mL) and dry MeCN (5 mL), cooled to -30 °C, followed by addition 
of NIS (336 mg; 1.5 mmol) and TESOTf (27 mg; 0.1 mmol). The 
reaction mixture was stirred at -30 °C until TLC revealed full con-
version of the donor (2 h). The solution was diluted with CH2Cl2 
(100 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. 
NaHCO3 (100 mL). The organic phase was dried over MgSO4, fil-
tered and concentrated. The product was purified by flash chroma-
tography (6:1 Tol/EtOAc) to afford 24 as an off-white solid. Rf 0.62 
(2:1 Tol/EtOAc). Yield: 1.6 g (80%). 1H NMR (400 MHz, CDCl3) 
δ 7.53 – 7.36 (m, 8H), 7.34 – 7.07 (m, 22H), 5.53 (s, 1H, CHbenzyli-
dene), 5.48 (s, 1H, CHbenzylidene), 5.46 (s, 1H, CHbenzylidene), 5.44 (s, 
1H, CHbenzylidene), 5.45 – 5.23 (m, 1H, H-21, H-25), 4.93 – 4.86 (m, 
2H, H-11/2/3/4/5, H-35), 4.83 (m, 2H, CH2Bn), 4.66 (d, J1,2 = 8.0 Hz, 
1H, H-11/2/3/4/5), 4.63 (d, J1,2 = 7.9 Hz, 1H, H-11/2/3/4/5), 4.54 (d, J1,2 
= 8.0 Hz, 1H, H-11/2/3/4/5), 4.49 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2Bn), 
4.44 (d, JCH2 = 12.3 Hz, 1H, 0.5xCH2Bn), 4.36 (d, J1,2 = 7.9 Hz, 1H, 
H-11/2/3/4/5), 4.33 – 3.87 (m, 20H, H-31, H-34, H-41/2/4/5, H-41/2/4/5, H-
41/2/4/5, H-41/2/4/5, H-61-H-65, CH2AcCl), 3.83 – 3.77 (m, 1H, H-43), 
3.43 – 3.38 (m, 2H, H-53, H-51/2/4/5), 3.34 – 3.24 (m, 3H, H-51/2/4/5, 
H-51/2/4/5, H-51/2/4/5), 1.84 (s, 3H, CH3Ac), 1.10 (s, 9H, 3xCH3Piv), 
1.07 (s, 9H, 3xCH3Piv), 1.04 (s, 9H, 3xCH3Piv), 1.02 (s, 9H, 
3xCH3Piv), 1.00 (s, 9H, 3xCH3Piv). 13C NMR (101 MHz, CDCl3) δ 
176.9, 176.2, 176.0, 175.9, 175.8, 170.3, 167.1, 138.3, 137.9, 
137.8, 137.7, 137.24, 137.15, 129.2-126.0 (30C), 100.9, 100.3 
(2C), 100.2, 100.13, 100.09, 100.0, 99.9, 99.1, 77.3, 75.8, 75.6, 
74.7, 74.4, 74.3, 73.5, 73.2, 73.0, 72.2, 71.81, 71.79, 71.76, 71.6, 
71.4, 70.9, 70.0, 68.8, 68.7, 68.6, 68.2, 67.4, 66.9, 66.7, 62.0, 40.6, 
38.8, 38.73, 38.66, 38.61, 38.57, 27.3 (3C), 27.23 (3C), 27.19 (3C), 
27.1 (3C), 27.0 (3C), 20.8. HRMS (MALDI) m/z: [M + Na] + Calcd 
for C101H124ClO33Na 1922.7605 Found 1922.7640. 
Benzyl 4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-
(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-
 (1→3)-6-O-acetyl-4-O-benzyl-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
noside (25). Compound 24 (3.0 g; 1.6 mmol) was dissolved in 30 
mL dry THF. Thiourea (481 mg; 6.3 mmol), Bu4NI (116 mg; 0.3 
mmol) and NaHCO3 (584 mg; 6.9 mmol) was added and the reac-
tion mixture was heated to 55 °C for 12 h. The mixture was filtered, 
concentrated and purified by flash chromatography (4:1 
Tol/EtOAc) to give 25 as a colorless syrup. Rf 0.49 (2:1 
Tol/EtOAc). Yield: 2.4 g (84%). IR (neat, cm-1): 3064.90, 2906.56, 
2871.51, 1740.83, 1479.69, 1454.99, 1397.85, 1366.58, 1276.77, 
1229.22, 1172.47, 1134.96, 1087.71, 1047.90, 1027.22. 1H NMR 
(400 MHz, CDCl3) δ 7.54 – 7.36 (m, 8H, Ar-H), 7.33 – 7.02 (m, 
22H, Ar-H), 5.52 (s, 1H, CHbenzylidene), 5.49 (s, 1H, CHbenzylidene), 
5.48 (s, 1H, CHbenzylidene), 5.46 (s, 1H, CHbenzylidene), 5.43 (dd, J2,3 = 
10.3, J1,2 = 7.9 Hz, 1H, H-21/2/4/5), 5.37 (dd, J2,3 = 10.2, J1,2 = 7.9 Hz, 
1H, , H-21/2/4/5), 5.28 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 2H, H-21/2/4/5, H-
21/2/4/5), 4.99 (dd, J = 10.1, 8.0 Hz, 1H, H-23), 4.85 (d, JCH2 = 11.9 
Hz, 1H, 0.5xCH2Bn), 4.81 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2Bn), 4.80 
(d, J1,2 = 8.0 Hz, 1H, H-13), 4.66 (d, J1,2 = 8.0 Hz, 1H, H-21/2/4/5), 
4.65 (d, J1,2 = 7.9 Hz, 1H, H-21/2/4/5), 4.54 (d, J1,2 = 8.0 Hz, 1H, H-
21/2/4/5), 4.51 (d, J = 12.0 Hz, 1H, 0.5xCH2Bn), 4.44 (d, JCH2 = 11.9 
Hz, 1H, 0.5xCH2Bn), 4.36 (d, J1,2 = 7.9 Hz, 1H, H-21/2/4/5), 4.31 – 
3.88 (m, 18H, H-31/2/4/5, H-31/2/4/5, H-31/2/4/5, H-31/2/4/5, 4xH-4, H-61-
H-65), 3.81 (dd, J3,4 = 2.9, J4,5 = 1.2Hz, 1H, H-4), 3.54 (dd, J2,3 = 
10.1, J3,4 = 3.7 Hz, 1H, H-33), 3.41 (dd, J5,6a = 7.4, J5,6b = 5.9 Hz, 
1H, H-53), 3.36 – 3.32 (m, 1H, H-51/2/4/5), 3.32 – 3.29 (m, 1H, H-
51/2/4/5), 3.28 (m, 2H, H-51/2/4/5), 1.84 (s, 3H, CH3Ac), 1.10 (s, 9H, 
3xCH3Piv), 1.07 (s, 9H, 3xCH3Piv), 1.06 (s, 9H, 3xCH3Piv), 1.04 (s, 
9H, 3xCH3Piv), 1.03 (s, 89H, 3xCH3Piv). 13C NMR (101 MHz, 
CDCl3) δ 178.9, 176.3, 176.1, 176.0, 175.9, 170.4, 138.4, 138.0, 
137.9, 137.8, 137.4, 137.3, 129.4-126.2 (30C), 101.4, 100.38, 
100.36 (2C), 100.2 (2C), 100.1, 100.0, 99.3, 77.4, 76.0, 75.9, 75.7 
(2C), 74.8, 74.6, 74.4, 73.1, 72.3, 72.2 (2C), 72.0, 71.92, 71.86, 
71.7, 71.5, 71.0, 70.1, 68.9, 68.8, 68.7, 68.1, 67.5 (2C), 67.1, 67.0, 
62.1, 39.0, 38.82, 38.76, 38.71, 38.69, 27.4 (3C), 27.34 (3C), 27.29 
(3C), 27.2 (3C), 27.1 (3C), 20.9. HRMS (ESI-TOF) m/z: [M + Na] 
+ Calcd for C99H122NaO32 1845.7817; Found 1845.7756. 
Benzyl 4,6-O-benzylidene-2,3-O-dipivaloyl-β-D-galactopyra-
nosyl--(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-(1→3)-4,6-
O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-
O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-6-O-
acetyl-4-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-
4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-
4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside (26). To 
a 25 mL flame-dried flask was added 25 (2.0 g, 1.1 mmol) and the 
20 (1.2 g, 1.4 mmol). The mixture was dried azeotropically with 
toluene (2x15 mL) and subjected to vacuum overnight. It was then 
dissolved in dry CH2Cl2 (7.5 mL) and dry MeCN (7.5 mL), cooled 
to -30 °C, followed by addition of NIS (329 mg; 1.5 mmol) and 
TESOTf (29 mg; 0.1 mmol). The reaction mixture was stirred at  
-30 °C until TLC revealed full conversion of the donor (2 h). The 
solution was diluted with CH2Cl2 (150 mL) and washed with sat. 
aq. NaS2O3 (150 mL) and sat. aq. NaHCO3 (150 mL). The organic 
phase was dried over MgSO4, filtered and concentrated. The prod-
uct was purified by flash chromatography (9:1 Tol/EtOAc) to af-
ford an off-white solid. Rf 0.66 (2:1 Tol/EtOAc). Yield: 2.2 g 
(78%). IR (neat, cm-1): 3539.46, 3064.70, 2972.47, 2932.93, 
2906.87, 2872.21, 1739.43, 1700.74, 1479.84, 1455.43, 1397.77, 
1367.06, 1276.81, 1172.99, 1086.91, 1048.10, 1000.89. 1H NMR 
(400 MHz, CDCl3) δ 7.64 – 7.44 (m, 12H, Ar-H), 7.44 – 7.13 (m, 
28H, Ar-H), 5.61 (s, 1H, CHbenzylidene), 5.59 (s, 1H, CHbenzylidene), 
5.57 (s, 2H, 2xCHbenzylidene), 5.56 (s, 1H, CHbenzylidene), 5.54 (s, 1H, 
CHbenzylidene), 5.52 – 5.34 (m, 7H, H-21-H-27), 4.96 – 4.87 (m, 3H, 
CH2Bn, H-1), 4.80 – 4.72 (m, 4H, 3xH-1, H-37), 4.70 (d, J1,2 = 7.9 
Hz, 1H, H-1), 4.64 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.62 (d, JCH2 = 12.1 
Hz, 1H, 0.5xCH2Bn), 4.55 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2Bn), 4.46 
(d, J1,2 = 7.9 Hz, 1H, H-1), 4.40 – 4.01 (m, 25H, H-31-H-36, H-41, 
H-42, H-44, H-45, H-46, H-47, H-61, H-62, H-6a3, H-64, H-65, H-66, 
H-67), 4.00 (dd, J6a,6b = 10.8, J5,6b = 6,6 Hz, 1H, H-6b3), 3.89 (d, J3,4 
= 3.3 Hz, 1H, H-43), 3.50 (t, J5,6a = J5,6b = 6.6 Hz, 1H, H-53), 3.45 
(s, 1H, H-51/2/4/5/6/7), 3.41 (s, 1H, H-51/2/4/5/6/7), 3.38 (s, 1H, H-
51/2/4/5/6/7), 3.34 (s, 2H, H-51/2/4/5/6/7, H-51/2/4/5/6/7), 3.31 (s, 1H, 
H-51/2/4/5/6/7), 1.93 (s, 3H, CH3Ac), 1.19 (s, 9H, 3xCH3Piv), 1.17 (s, 
18H, 3xCH3Piv), 1.13 (s, 9H, 3xCH3Piv), 1.13 (s, 9H, 3xCH3Piv), 1.13 
(s, 9H, 3xCH3Piv), 1.11 (s, 9H, 3xCH3Piv), 1.10 (s, 9H, 3xCH3Piv). 
13C NMR (101 MHz, CDCl3) δ 178.1, 176.8, 176.2, 176.1, 175.99, 
175.95, 175.93, 175.8, 170.2, 137.92, 137.88, 137.86, 137.8, 137.7, 
137.5, 137.2, 136.4, 129.7-125.3 (40C), 100.4-99.2 (13C), 75.8-
62.1 (35C), 38.93, 38.90, 38.72, 38.68, 38.65, 38.61, 38.60, 38.58, 
27.3 (3C), 27.22 (3C), 27.19 (3C), 27.19 (3C), 27.16 (3C), 27.14 
(3C), 27.05 (3C), 27.0 (3C), 20.8. HRMS (ESI-TOF) m/z: 
[M+2Na]2+ Calcd for C140H174Na2O45 1311.0573; Found 
1311.0536.  
Benzyl 4,6-O-benzylidene-2,3-O-dipivaloyl-β-D-galactopyra-
nosyl--(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopy-
ranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopy-
ranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopy-
ranosyl-(1→3)-4-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl- 
(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-
(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside 
(27). 26 (2 g; 0.8 mmol) was dissolved in dry CH2Cl2 (20 mL) and 
cooled to 0 °C. A 1 M L-selectride solution in THF (3.1 mL) was 
added and the reaction was stirred at 0 °C until complete consump-
tion of the starting material (1 h). The reaction mixture was poured 
into sat. aq. NH4Cl (100 mL). The aqueous phase was extract with 
CH2Cl2 (100 mL) and the combined organic phase was dried over 
MgSO4, filtered and concentrated (avoid concentrating to dryness 
since the borane salts can be explosive). The crude product was pu-
rified by flash chromatography to give an off-white solid. Yield: 
1.6 g (79%). IR (neat, cm-1): 3511.92, 2972.77, 2933.51, 2907.86, 
2873.19, 1736.95, 1700.87, 1479.95, 1397.88, 1366.87, 1276.67, 
1168.85, 1135.17, 1080.83, 1046.25. 1H NMR (400 MHz, CDCl3) 
δ 7.51 – 7.07 (m, 40H, Ar-H), 5.50 (s, 1H, CHbenzylidene), 5.48 (s, 
1H, CHbenzylidene), 5.47 (s, 2H, 2xCHbenzylidene), 5.45 (s, 1H, CHbenzyl-
idene), 5.43 (s, 1H, CHbenzylidene), 5.42 – 5.04 (m, 7H, 7xH-2), 4.88 – 
4.74 (m, 3H, H-1, CH2Bn), 4.73 – 4.53 (m, 4H, 4xH-1, H-37), 4.48 
(d, J1,2 = 7.7 Hz, 1H, H-1), 4.44 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2Bn), 
4.36 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.31 (d, J3,4 = 4.0 Hz, 1H, H-4), 
4.29 – 3.80 (m, 23H, 6xH-3, 5xH-4, 6xH-6), 3.75 (d, J3,4 = 3.2 Hz, 
1H, H-4), 3.52 (dd, J6a,6b = 11.3, J5,6a = 5.8 Hz, 1H, H-6a), 3.41 – 
3.35 (m, 1H, H-6b), 3.35 (s, 2H, 2xH-5), 3.31 (s, 1H, H-5), 3.27 (s, 
1H, H-5), 3.26 – 3.24 (m, 2H, 2xH-5), 3.22 (s, 1H, H-5), 1.97 (s, 
1H, -OH), 1.11 (s, 9H, 3xCH3Piv), 1.06 (s, 9H, 3xCH3Piv), 1.05 (s, 
9H, 3xCH3Piv), 1.04 (s, 9H, 3xCH3Piv), 1.03 (s, 9H, 3xCH3Piv), 1.03 
(s, 9H, 3xCH3Piv), 1.00 (s, 9H, 3xCH3Piv), 0.98 (s, 9H, 3xCH3Piv). 
13C NMR (101 MHz, CDCl3) δ 178.3, 176.9, 176.3, 176.23, 
176.20, 176.08, 176.06, 176.0, 138.1, 138.0, 137.90, 137.87, 
137.86, 137.6, 137.3, 136.6, 129.9-125.4 (40C), 100.6-99.3 (13C), 
75.9-66.9 (35C), 39.04, 39.03, 38.9, 38.81, 38.79, 38.74, 38.73, 
38.69, 27.5 (3C), 27.4 (3C), 27.33 (3C), 27.32 (3C), 27.28 (3C), 
27.24 (3C), 27.18 (3C), 27.12 (3C). HRMS (ESI-TOF) m/z: 
[M+2Na]2+ Calcd for C138H172Na2O44 1290.0520; Found 
1290.0459. 
Benzyl 4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-O-4,6-O-benzylidene-2-O-pivaloyl-β-
D-galactopyranoside (28).  To a 50 mL flame-dried flask was 
added 16 (2.0 g, 2.57 mmol) and the 15b (2.6 g, 3.09 mmol). The 
 mixture was dried azeotropically with toluene (2x30 mL) and sub-
jected to vacuum overnight. It was then dissolved in dry CH2Cl2 
(15 mL) and dry MeCN (15 mL), cooled to -30 °C, followed by 
addition of NIS (723 mg; 3.21 mmol) and TESOTf (68 mg; 
0.26 mmol). The reaction mixture was stirred at -30 °C until TLC 
revealed full conversion of the donor (1½h). The solution was di-
luted with CH2Cl2 (150 mL) and washed with sat. aq. NaS2O3 
(150 mL) and sat. aq. NaHCO3 (150 mL). The organic phase was 
dried over MgSO4, filtered and concentrated. The product was pu-
rified by flash chromatography (9:1 toluene/EtOAc) to afford a 
white solid. Rf 0.13 (9:1 Tol/EtOAc). Yield: 3.1 g (88%). 1H NMR 
(400 MHz, CDCl3) δ 7.50 – 7.36 (m, 8H), 7.33 – 7.14 (m, 17H), 
5.49 (s, 1H, CHbenzylidene), 5.48 (s, 1H, CHbenzylidene), 5.46 (s, 1H, 
CHbenzylidene), 5.42 (s, 1H, CHbenzylidene), 5.39 (dd, J2,3 = 10.3, J3,4 = 
7.9 Hz, 1H, H-21/2/3/4), 5.36 – 5.27 (m, 3H, H-21/2/3/4, H-21/2/3/4, H-
21/2/3/4 ), 4.88 (d, J1,2 = 8.0 Hz, 1H, H-11/2/3/4), 4.86 (dd, J2,3 = 10.5, 
J3,4 = 3.6 Hz, 1H, H-34), 4.82 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2Bn), 
4.68 (d, J1,2 = 7.9 Hz, 1H, H-11/2/3/4), 4.67 (d, J = 7.9 Hz, 1H, H-
11/2/3/4), 4.44 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2Bn), 4.35 (d, J1,2 = 7.9 
Hz, 1H, H-11/2/3/4), 4.30 – 3.84 (m, 17H, H-31-H-33, H-41-H-44, H-
61-H-64, CH2AcCl), 3.35 (m, 1H, H-51/2/3/4), 3.30 (m, 1H, H-51/2/3/4), 
3.25 (m, 1H, H-51/2/3/4), 3.24 (m, 1H, H-51/2/3/4), 1.08 (s, 9H, 
3xCH3Piv), 1.05 (s, 9H, 3xCH3Piv), 1.03 (s, 9H, 3xCH3Piv), 1.01 (s, 
9H, 3xCH3Piv). 13C NMR (101 MHz, CDCl3) δ 176.9, 176.1, 
175.98, 175.96, 167.1, 137.9, 137.8, 137. 7, 137.3, 137.2, 129.2-
125.3 (25C), 100.9, 100.3 (2C), 100.1 (2C), 100.0, 99.7, 99.1, 75.9 
(2C), 75.6, 73.5, 73.3, 72.1, 71.9, 71.5, 71.1, 70.8, 70.0, 69.8, 68.6, 
68.5, 68.3, 67.41, 67.36, 66.9, 66.6, 40.6, 38.8, 38.7, 38.6 (2C), 
27.3-21.5 (12C). HRMS (MALDI) m/z: [M + Na] + Calcd for 
C81H98ClO26Na 1544.5927 Found 1544.5896. 
Benzyl 4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-
(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-
(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-
(1→3)-4,6-O-benzylidene-2-pivaloyl-β-D-galactopyranoside 
(29). 28 (2.5 g; 1.6 mmol) was dissolved in dry CH2Cl2 (30 mL) 
and cooled to 0 °C. A 1 M L-selectride solution in THF (4.9 mL) 
was added and the reaction was stirred at 0 °C until complete con-
sumption of the starting material (0.5 h). The reaction mixture was 
poured into sat. aq. NH4Cl (100 mL). The aqueous phase was ex-
tracted with CH2Cl2 (100 mL). The combined organic phase was 
dried over MgSO4, filtered and concentrated (avoid concentrating 
to dryness since the borane salts can be explosive). The crude prod-
uct was purified by flash chromatography (4:1 Tol/EtOAc) to give 
a white solid. Rf 0.46 (2:1 Tol/EtOAc). Yield: 2.2 g (94%). 1H 
NMR (400 MHz, CDCl3) δ 7.55 – 7.34 (m, 8H), 7.34 – 7.11 (m, 
17H), 5.53 – 5.44 (m, 4H, 4xCHbenzylidene), 5.39 (dd, J2,3 = 9.8, J1,2 
= 7.4 Hz, 1H, H-21/2/3/4), 5.34 (m, 2H, H-21/2/3/4, H-21/2/3/4), 4.97 (dd, 
J2,3 = 10.0, J1,2 = 8.0 Hz, 1H, H-24), 4.82 (d, JCH2 = 11.9 Hz, 1H, 
0.5xCH2Bn), 4.77 (d, J1,2 = 8.0 Hz, 1H, H-14), 4.69 (d, J1,2 = 7.9 Hz, 
1H, H-11/2/3/4), 4.68 (d, J1,2 = 8.0 Hz, 1H, H-11/2/3/4), 4.44 (d, JCH2 = 
11.9 Hz, 1H, 0.5xCH2Bn), 4.36 (d, J1,2 = 7.8 Hz, 1H, H-11/2/3/4), 4.31 
– 3.90 (m, 15H, H-31-H-33, H-41-H-44, H-61-H-64), 3.51 (td, J2,3 = 
10.3, J3,4 = 3.6 Hz, 1H, H-34), 3.37 – 3.21 (m, 4H, H-51-H-54), 1.07 
(s, 9H, 3xCH3Piv), 1.06 (s, 9H, 3xCH3Piv), 1.05 (s, 9H, 3xCH3Piv), 
1.03 (s, 9H, 3xCH3Piv). 13C NMR (101 MHz, CDCl3) δ 178.8, 
176.1, 175.99, 175.97, 137.9, 137.8, 137.7, 137.3, 137.2, 129.3-
126.1 (25C), 101.3, 100.3 (2C), 100.3, 100.2, 100.0, 99.6, 99.2, 
77.3, 76.0, 75.9, 75.6 (2C), 72.4, 72.1, 72.0, 71.9, 71.5, 71.1, 70.9, 
70.0, 68.8, 68.7, 68.6, 67.41, 67.37, 66.93, 66.89, 38.9, 38.7, 38.6, 
38.6, 27.23, 27.20, 27.16, 27.0. HRMS (MALDI) m/z: [M + Na] + 
Calcd for C79H96O25Na 1467.6133 Found 1467.6114. 
Benzyl 6-O-acetyl-4-O-benzyl-3-O-chloroacetyl-2-O-pivaloyl-
β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-
β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-
β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-
β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-
β-D-galactopyranoside (30). To a 25 mL flame-dried flask was 
added 29 (2.8 g, 1.93 mmol) and the 21 (1.5 g, 2.7 mmol). The 
mixture was dried azeotropically with toluene (2x25 mL) and sub-
jected to vacuum overnight. It was then dissolved in dry CH2Cl2 
(12.5 mL) and dry MeCN (12.5 mL), cooled to -30 °C, followed by 
addition of NIS (651 mg; 2.90 mmol) and TESOTf (51 mg; 
0.19 mmol). The reaction mixture was stirred at - 30 °C until TLC 
revealed full conversion of the donor (3 h). The solution was di-
luted with CH2Cl2 (150 mL) and washed with sat. aq. NaS2O3 
(150 mL) and sat. aq. NaHCO3 (150 mL). The organic phase was 
dried over MgSO4, filtered and concentrated. The product was pu-
rified by flash chromatography (4:1 Tol/EtOAc) to afford 30 as a 
white solid. Rf 0.64 (2:1 Tol/ EtOAc). Yield: 2.5 g (69%). 1H NMR 
(400 MHz, CDCl3) δ 7.50 – 7.37 (m, 8H), 7.32 – 7.14 (m, 17H), 
5.48 (s, 1H, CHbenzylidene), 5.47 (s, 1H, CHbenzylidene), 5.46 (s, 2H, 
2xCHbenzylidene), 5.39 (dd, J2,3 = 10.2, J1,2 = 7.9 Hz, 1H, H-21/2/3/4/5), 
5.33 (dd, J2,3 = 10.5, J1,2 = 8.0 Hz, 1H, H-21/2/3/4/5), 5.30 – 5.23 (m, 
3H, H-21/2/3/4/5, H-21/2/3/4/5, H-21/2/3/4/5), 4.87 (dd, J2,3 = 10.2, J3,4 = 
3.1 Hz, 1H, H-35), 4.82 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2Bn), 4.71 
(d, J1,2 = 7.7 Hz, 1H, H-11/2/3/4/5), 4.66 (m, 3H, H-11/2/3/4/5, H-
11/2/3/4/5, H-11/2/3/4/5), 4.62 (d, JCH2 = 12.5 Hz, 1H, 0.5xCH2Bn), 
4.50 (d, JCH2 = 11.6 Hz, 1H, 0.5xCH2Bn), 4.44 (d, JCH2 = 11.9 Hz, 
1H, 0.5xCH2Bn), 4.36 (d, J = 7.9 Hz, 1H, H-11/2/3/4/5), 4.30 – 3.90 
(m, 18H, H-31-H-34, H-41-H-44, H-61-H-65), 3.84 (d, J3,4 = 2.8 Hz, 
1H, H-45), 3.79 (d, JCH2 = 15.0 Hz, 1H, 0.5xCH2AcCl), 3.72 (d, JCH2 
= 15.0 Hz, 1H, 0.5xCH2AcCl), 3.60 (t, J5,6a = J5,6b = 6.5 Hz, 1H, H-
55), 3.31 (s, 1H, H-51/2/3/4), 3.27 – 3.23 (m, 2H, H-51/2/3/4), 3.21 (s, 
1H, H-51/2/3/4), 1.94 (s, 3H, CH3Ac), 1.07 (s, 9H, 3xCH3Piv), 1.04 (s, 
9H, 3xCH3Piv), 1.01 (s, 9H, 3xCH3Piv), 1.01 (s, 9H, 3xCH3Piv), 1.00 
(s, 9H, 3xCH3Piv). 13C NMR (101 MHz, CDCl3) δ 177.0, 176.04, 
176.01, 175.97, 175.93, 170.2, 166.7, 137.9, 137.8, 137.73, 137.65, 
137.19, 137.17, 129.0-126.0 (30C), 100.4, 100.34, 100.26, 100.2, 
100.1, 100.0, 99.7, 99.6, 99.5, 77.3, 75.9, 75.8, 75.6, 75.1, 74.9, 
73.6, 72.6, 71.9, 71.8, 71.5, 71.4, 71.2, 71.1, 71.0, 70.0, 68.9, 68.8, 
68.7, 68.5, 67.5, 67.4, 67.3, 66.9, 62.1, 40.3, 38.8, 38.7, 38.63, 
38.59 (2C), 27.21 (3C), 27.19 (6C), 27.1 (3C), 27.0 (3C), 20.8. 
HRMS (MALDI) m/z: [M + H] + Calcd for C101H125ClO33 
1900.7786 Found 1900.7671, [M + Na]+ Calcd for 
C101H124ClO33Na 1922.7605 Found 1922.7614. 
Benzyl 6-O-acetyl-4-O-benzyl-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
noside (31). 30 (2.0 g; 1.05 mmol) was dissolved in 30 mL dry 
THF. Thiourea (481 mg; 6.3 mmol), Bu4NI (389 mg; 1.05 mmol) 
and NaHCO3 (265 mg; 3.15 mmol) was added and the reaction 
mixture was heated to 55 °C for 12 h. The mixture was filtered, 
concentrated and purified by flash chromatography (19:1 
Tol/EtOAc) to give 31 as colorless syrup. Rf 0.48 (9:1 Tol/EtOAc). 
Yield: 1.6 g (83%). IR (neat, cm-1): 3524.49, 3089.87, 2972.59, 
2931.86, 2906.24, 2871.90, 1741.17, 1497.18, 1479.57, 1397.64, 
1366.55, 1277.25, 1232.63, 1173.45, 1088.19, 1048.36, 1027.67. 
1H NMR (400 MHz, CDCl3) δ 7.49 – 7.35 (m, 12H), 7.32 – 7.13 
(m, 18H), 5.48 (s, 1H, CHbenzylidene), 5.47 (s, 1H, CHbenzylidene), 5.46 
(s, 1H, CHbenzylidene), 5.45 (s, 1H, CHbenzylidene), 5.39 (dd, J2,3 = 10.1, 
J1,2 = 8.1 Hz, 1H, H-2), 5.36 – 5.26 (m, 4H, 4xH-2), 4.85 (d, JCH2 = 
12.2 Hz, 1H, 0.5xCH2Bn), 4.83 (d, J2,3 = 10.1, J3,4 = 3.2 Hz, 1H, H-
21), 4.75 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2Bn), 4.69 – 4.59 (m, 4H, 
H-12-H-15), 4.61 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2Bn), 4.45 (d, JCH2 
= 11.9 Hz, 1H, 0.5xCH2Bn), 4.36 (d, J1,2 = 7.9 Hz, 1H, H-11), 4.29 
– 3.93 (m, 18H, 4xH-3, H-41-H-44, 5xH-6), 3.89 (dd, J2,3 = 10.3, 
J3,4 = 3.2 Hz, 1H, H-3), 3.69 (d, J3,4 = 2.7 Hz, 1H, H-45), 3.49 (t, 
J5,6a = J5,6b = 6.8 Hz, 1H, H-55), 3.31 (s, 1H, H-51/2/3/4), 3.26 (s, 2H, 
H-51/2/3/4, H-51/2/3/4), 3.22 (s, 1H, H-51/2/3/4), 1.94 (s, 3H, CH3Ac), 
 1.07 (s, 9H, 3xCH3Piv), 1.06 (s, 9H, 3xCH3Piv), 1.04 (s, 9H, 
3xCH3Piv), 1.02 (s, 9H, 3xCH3Piv), 1.01 (s, 9H, 3xCH3Piv). 13C NMR 
(101 MHz, CDCl3) δ 180.3, 176.14, 176.08 (2C), 176.0, 170.4, 
138.0, 137.87, 137.85, 137.73, 137.69, 137.3, 128.7-126.2 (30C), 
100.5, 100.44 (2C), 100.41, 100.39, 100.2, 100.1, 99.8, 99.7, 99.6, 
77.4, 76.2, 76.0, 75.9, 75.8, 75.7, 73.9, 73.6, 72.8, 72.7, 72.0, 71.9, 
71.6, 71.3, 71.2, 71.1, 70.1, 68.9, 68.7, 68.6, 67.6, 67.5, 67.4, 67.0, 
62.7, 39.1, 38.8, 38.73, 38.69, 38.66, 27.31 (3C), 27.28 (6C), 27.21 
(3C), 27.0 (3C), 20.9 (3C). HRMS (MALDI) m/z: [M + Na]+ Calcd 
for C99H122O32Na 1845.7811 Found 1845.7806. 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-6-O-acetyl-4-O-benzyl-2-O-pivaloyl-β-D-galacto-
pyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galacto-
pyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galacto-
pyranosyl-(1→3)-4,6-benzylidene-2-O-pivaloyl-β-D-galactopy-
ranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopy-
ranoside (32). To a 25 mL flame-dried flask was added 31 (1.8 g, 
0.99 mmol) and 20 (1.1 g, 1.3 mmol). The mixture was dried azeo-
tropically with toluene (2x10 mL) and subjected to vacuum over-
night. It was then dissolved in dry CH2Cl2 (5 mL) and dry MeCN 
(5 mL), cooled to -30 °C, followed by addition of NIS (294 mg; 
1.31 mmol) and TESOTf (26 mg; 0.1 mmol). The reaction mixture 
was stirred at -30 °C until TLC revealed full conversion of the do-
nor (3 h). The solution was diluted with CH2Cl2 (100 mL) and 
washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 
(100 mL). The organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography 
(19:1 Tol/EtOAc) to afford a white solid. Rf  0.58 (9:1 Tol/EtOAc). 
Yield: 1.95 g (77%). IR (neat, cm-1): 3065.85, 3035.79, 2972.47, 
2871.63, 1738.98, 1479.57, 1454.98, 1397.69, 1366.40, 1276.70, 
1172.84, 1132.25, 1087.66, 1047.67, 1027.15. 1H NMR (400 MHz, 
CDCl3) δ 7.61 – 6.91 (m, 40H, Ar-H), 5.51 (s, 1H, CHbenzylidene), 
5.48 (s, 1H, CHbenzylidene), 5.46 (s, 2H, 2xCHbenzylidene), 5.45 (s, 2H, 
2xCHbenzylidene), 5.44 – 5.18 (m, 7H, 7xH-2), 4.83 (d, J = 8.1 Hz, 
1H, H-1), 4.83 (d, JCH2 = 11.7 Hz, 1H, 0.5xCH2Bn), 4.82 (d, JCH2 
=11.9 Hz, 1H, 0.5xCH2Bn), 4.70 (dd, J2,3 = 10.5, J3,4 = 3.7 Hz, 1H, 
H-37), 4.68 – 4.57 (m, 4H, 4xH-1), 4.52 (d, J1,2 = 7.7 Hz, 1H, H-1), 
4.49 (d, JCH2 = 11.7 Hz, 1H, 0.5xCH2Bn), 4.44 (d, JCH2 = 11.9 Hz, 
1H, 0.5xCH2Bn), 4.35 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.33 (d, J3,4 = 3.8 
Hz, 1H, H-4), 4.27 (d, J3,4 = 3.3 Hz, 1H, H-4), 4.26 – 3.93 (m, 24H, 
6xH-3, 5xH-4, 6.5xH-6), 3.90 (dd, J6a,6b = 11.0, J5,6b = 7.1 Hz, 1H, 
H-6b5), 3.78 (s, 1H, H-5), 3.41 (t, J5,6a = J5,6b = 6.6 Hz, 1H, H-55), 
3.38 (s, 1H, H-5), 3.29 (s, 1H, H-5), 3.23 (m, 2H, 2xH-5), 3.21 (s, 
1H, H-5), 1.83 (s, 3H, CH3Ac), 1.10 (s, 9H, 3xCH3Piv), 1.07 (s, 18H, 
6xCH3Piv), 1.04 (s, 9H, 3xCH3Piv), 1.02 (s, 9H, 3xCH3Piv), 1.00 (s, 
18H, 6xCH3Piv), 0.99 (s, 9H, 3xCH3Piv). 13C NMR (101 MHz, 
CDCl3) δ 178.2, 177.0, 176.4, 176.2, 176.15, 176.06, 176.0, 175.9, 
170.4, 138.4, 138.0, 137.89, 137.86 (2C), 137.8, 137.6, 137.3, 
129.1-126.0 (40C), 100.5, 100.4 (2C), 100.33, 100.30, 100.2 (2C), 
100.13, 100.09, 100.0, 99.7, 99.2, 77.4, 76.0, 75.9, 75.8, 75.72, 
75.71, 74.8, 74.5, 74.4, 73.1 (2C), 72.3, 71.99, 71.96, 71.9, 71.7, 
71.6, 71.6, 71.5, 71.4, 71.3, 71.2, 71.1, 70.1, 68.8 (2C), 68.7, 68.6 
(2C), 68.3, 67.6, 67.5 (2C), 67.0, 66.9, 62.3, 39.0, 38.81, 38.76 
(2C), 38.71, 38.66, 38.65 (2C), 27.4 (3C), 27.29 (6C), 27.26 (3C), 
27.24 (3C), 27.19 (3C), 27.1 (6C), 20.9. HRMS (MALDI) m/z: [M 
+ Na]+ Calcd for C140H174O45Na 2598.1219 Found 2598.1299. 
Benzyl 4,6-O-benzylidene-2,3-O-dipivaloyl-β-D-galactopyra-
nosyl--(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopy-
ranosyl-(1→3)-6-O-acetyl-4-O-benzyl-3-O-chloroacetyl-2-O-
pivaloyl-β-D-galactopyranosyl- (1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranoside (33). 32 (2 g; 0.8 mmol) was dis-
solved in dry CH2Cl2 (20 mL) and cooled to 0 °C. A 1 M L-selec-
tride solution in THF (3.1 mL) was added and the reaction was 
stirred at 0 °C until complete consumption of the starting material 
(1 h). The reaction mixture was poured into sat. aq. NH4Cl 
(100 mL). The aqueous phase was extract with CH2Cl2 (100 mL) 
and the combined organic phase was dried over MgSO4, filtered 
and concentrated (avoid concentrating to dryness since the borane 
salts can be explosive). The crude product was purified by flash 
chromatography (9:1 Tol/EtOAc) to give 33 as a colorless solid 
material. Yield: 1.6 g (79%). 1H NMR (400 MHz, CDCl3) δ 7.52 – 
7.02 (m, 40H), 5.50 (s, 1H, CHbenzylidene), 5.47 (s, 1H, CHbenzylidene), 
5.45 (m, 4H, 4xCHbenzylidene), 5.43 – 5.16 (m, 7H, 7xH-2), 4.84 (d, 
J1,2 = 7.7 Hz, 1H, H-1), 4.82 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2Bn), 
4.79 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2Bn), 4.70 (dd, J2,3 = 10.3, J3,4 = 
3.7 Hz, 1H, H-37), 4.67 (d, J1,2 = 7.8 Hz, 1H, H-1), 4.64 (d, J1,2 = 
7.5 Hz, 1H, H-1), 4.62 (d, J1,2 = 7.5 Hz, 1H, H-1), 4.61 (d, J1,2 = 7.7 
Hz, 1H, H-1), 4.57 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.56 (d, JCH2 = 12.1 
Hz, 1H, 0.5xCH2Bn), 4.45 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2Bn), 4.36 
(d, J1,2 = 7.9 Hz, 1H, H-1), 4.33 (d, J3,4 = 3.8 Hz, 1H, H-4), 4.29 – 
3.88 (m, 23H, 6xH-3, 5xH-4, 6xH-6), 3.74 (d, J3,4 = 3.1 Hz, 1H, H-
4), 3.52 (dd, J6a,6b = 11.6, J5,6a = 5.9 Hz, 1H, H-6a5), 3.39 (s, 1H, H-
5), 3.40 – 3.31 (m, 1H, H-6b5), 3.30 (s, 1H, H-5), 3.24 (s, 2H, 2xH-
5), 3.23 (s, 1H, H-5), 3.21 – 3.19 (m, 2H, 2xH-5), 2.08 (s, 1H, -
OH), 1.12 (s, 9H, 3xCH3Piv), 1.07 (s, 18H, 6xCH3Piv), 1.04 (s, 9H, 
3xCH3Piv), 1.03 (s, 9H, 3xCH3Piv), 1.00 (s, 9H, 3xCH3Piv), 0.98 (s, 
9H, 3xCH3Piv), 0.97 (s, 9H, 3xCH3Piv). 13C NMR (101 MHz, 
CDCl3) δ 178.2, 177.0, 176.4, 176.3, 176.1, 176.1, 176.0, 176.0, 
138.3, 138.01, 137.99, 137.98, 137.91, 137.87, 137.6, 137.3, 129.9-
125.4 (40C), 100.6-99.2 (13C), 77.5, 76.2, 76.0, 75.9, 75.80, 75.78, 
75.7, 75.0, 74.7, 74.2, 73.2, 72.5, 72.0, 71.9, 71.7, 71.6, 71.5, 71.4, 
71.3, 71.2, 70.1, 70.0, 68.9, 68.8, 68.7, 68.6, 68.4, 67.6, 67.53, 
67.52, 67.49, 67.1, 66.9, 39.0, 38.9, 38.79, 38.78, 38.77, 38.74, 
38.73, 38.69, 27.5 (3C), 27.4 (3C), 27.32 (3C), 27.29 (3C), 27.27 
(3C), 27.25 (3C), 27.11 (3C), 27.10 (3C). HRMS (MALDI) m/z: 
[M + Na]+ Calcd for C99H122O32Na 1845.7811 Found 1845.7806. 
Phenyl 2,3,5-tri-O-benzoyl-1-thio-α-L-arabinofuranoside (34). 
To a solution of methyl 2,3,5-tri-O-benzoyl-α-L-arabinofuranoside 
(7.8 g, 16.4 mmol) in CH2Cl2 (200 mL) at 0 °C was added thiophe-
nol (2.4 mL, 22.4 mmol) dropwise. The reaction mixture was 
stirred at 0 °C for 15 min, then BF3·Et2O (13.6 mL, 107.2 mmol) 
was added and the resulting mixture was warmed gradually to 
22 °C. The reaction was stirred for 8 h at 22 °C. The reaction mix-
ture was poured into sat. aq. NaHCO3 (100 mL). The water phase 
was extracted with CH2Cl2 (50 mL). The combined organic phases 
were dried over MgSO4, filtered and concentrated. The resulting 
residue was purified by column chromatography (20:1 Tol/EtOAc) 
to afford 34 as an amorphous solid. Rf 0.65 (9:1 Tol/EtOAc). Yield: 
7.4 g (81%). IR (neat, cm-1): 3061.69, 1721.80, 1601.55, 1584.07, 
1480.24, 1451.45, 1440.37, 1315.28, 1266.25, 1177.61, 1107.62, 
1095.64, 1069.33, 1026.52 1H NMR (400 MHz, CDCl3) δ 8.06 (m, 
2H, Ar-H), 8.03 – 7.91 (m, 4H, Ar-H), 7.62 – 7.14 (m, 14H, Ar-H), 
5.77 (d, J = 3.7 Hz, 1H, H-1), 5.70 – 5.63 (m, 1H, H-2), 5.60 (s, 
1H, H-3), 4.91 – 4.60 (m, 2H, H-4, H-5a, H-5b). 13C NMR (101 
MHz, CDCl3) δ 166.2, 165.6, 165.4, 133.7-127.9 (24C), 91.5, 82.6, 
81.2, 78.1, 63.5. HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for 
C138H172O44Na 2556.1113 Found 2556.1149. 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-[2,3,5-tri-O-benzoyl-α-L-arabinosyl-(1→6)]-4-O-
benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-ben-
zylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-ben-
zylidene-2-O-pivaloyl-β-D-galactopyranoside (36). To a 25 mL 
 flame-dried flask was added 27 (600 mg, 0.24 mmol) and the 34 
(197 mg, 0.36 mmol). The mixture was dried azeotropically with 
toluene (2x5 mL) and subjected to vacuum overnight. It was then 
dissolved in dry CH2Cl2 (2 mL) and dry MeCN (2 mL), cooled to  
-30 °C, followed by addition of NIS (82 mg; 0.37 mmol) and 
TESOTf (13 mg; 0.05 mmol). The reaction mixture was stirred at  
-30 °C until TLC revealed full conversion of the donor (1 h). The 
solution was diluted with CH2Cl2 (50 mL) and washed with sat. aq. 
NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The organic phase 
was dried over MgSO4, filtered and concentrated. The product was 
purified by flash chromatography (19:1 Tol/EtOAc) to afford a 
white solid. Yield: 486 mg (69%). IR (neat, cm-1): 3090.00, 
3065.36, 2972.21, 2933.47, 2907.23, 2872.02, 1722.44, 1452.75, 
1366.69, 1269.93, 1174.22, 1130.12, 1088.96, 1048.87, 1026.90 
1H NMR (400 MHz, CDCl3) δ 8.04 (dd, J = 8.0, 1.0 Hz, 2H, Ar-
HBz), 8.00 (dd, J = 8.2, 1.3 Hz, 1H, Ar-HBz), 7.96 (dd, J = 8.1, 1.2 
Hz, 2H, Ar-HBz), 7.60 – 7.46 (m, 12H, Ar-H), 7.46 – 7.24 (m, 31H, 
Ar-H), 7.24 – 7.14 (m, 6H, Ar-H), 5.65 (s, 1H, CHbenzylidene), 5.59 – 
5.56 (m, 4H, 4xCHbenzylidene), 5.55 (s, 1H, CHbenzylidene), 5.54 – 5.33 
(m, 9H, H-21-H-27, H-2’, H-3’), 5.25 (s, 1H, H-1’), 4.94 (d, J1,2 = 
7.9 Hz, 1H, H-1), 4.92 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2Bn), 4.81 
(dd, J2,3 = 10.0, J3,4 = 3.1 Hz, 1H, H-37), 4.79 (d, JCH2 = 11.9 Hz, 
1H, 0.5xCH2Bn), 4.78 – 4.72 (m, 4H, 4xH-1), 4.69 (d, J1,2 = 8.0 Hz, 
1H, H-1), 4.64 (dd, J5a,5b = 12.1, J4,5a = 3.4 Hz, 1H, H-5a’), 4.55 (d, 
JCH2 = 11.9 Hz, 1H, 0.5xCH2Bn), 4.48 (dd J5a,5b = 12.1, J4,5a = 4.7 
Hz, 1H, H-5b’), 4.45 – 4.02 (m, 27H, H-1, H-31-H-36, 6xH-
41/2/4/5/6/7, 6xH-61/2/4/5/6/7, H-4’, 0.5xCH2Bn), 3.94 (d, J3,4 = 3.7 Hz, 
1H, H-43), 3.92 (dd, J6a,6b = 9.6, J5,6a = 6.6 Hz, 1H, H-6a3), 3.66 (t, 
J5,6a = J5,6b = 6.6 Hz, 1H, H-53), 3.56 (dd, J6a,6b = 9.6, J5,6b = 6.6 Hz, 
1H, H-6b3), 3.50 (s, 1H, H-41/2/4/5/6/7), 3.48 (s, 1H, H-41/2/4/5/6/7), 3.41 
(s, 1H, H-41/2/4/5/6/7), 3.37 (s, 1H, H-41/2/4/5/6/7), 3.35 (s, 1H, H-
41/2/4/5/6/7), 3.31 (s, 1H, H-41/2/4/5/6/7), 1.19 (s, 9H, 3xCH3Piv), 1.17 (s, 
9H, 3xCH3Piv), 1.15 (s, 9H, 3xCH3Piv), 1.15 (s, 18H, 6xCH3Piv), 1.10 
(s, 18H, 6xCH3Piv), 1.05 (s, 9H, 3xCH3Piv). 13C NMR (101 MHz, 
CDCl3) δ 178.3, 177.0, 176.2, 176.1 (2C), 176.0, 175.94, 175.92, 
166.3, 165.8, 165.5, 138.8, 137.98, 137.95 (2C), 137.9, 137.8, 
137.6, 137.3, 134.1, 133.7, 133.2, 130.2-125.4 (55C), 106.4, 100.6, 
100.5 (2C), 100.4, 100.3, 100.24 (2C), 100.21 (2C), 100.1, 99.84, 
99.80, 99.4, 82.1, 81.5, 77.6, 77.4, 76.9, 76.1, 76.03, 76.99, 75.91, 
75.86, 75.7, 74.5, 74.4, 74.2, 73.1, 72.4, 72.01, 71.96, 71.9, 71.6, 
71.5, 71.3, 71.0, 70.1, 68.9, 68.8, 68.6, 68.4, 67.8, 67.6, 67.5, 67.4, 
67.1, 67.0, 66.1, 63.6, 39.0, 38.83, 38.77, 38.73, 38.70 (2C), 38.68, 
38.65, 27.4 (3C), 27.4 (3C), 27.32 (6C), 27.26 (3C), 27.2 (6C), 27.1 
(3C). 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-[2,3,5-tri-O-benzoyl-α-L-arabinosyl-(1→6)]-4-O-
benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-ben-
zylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-ben-
zylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-ben-
zylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-ben-
zylidene-2-O-pivaloyl-β-D-galactopyranoside (38). To a 25 mL 
flame-dried flask was added 33 (400 mg, 0.13 mmol) and the 34 
(111 mg, 0.20 mmol). The mixture was dried azeotropically with 
toluene (2x5 mL) and subjected to vacuum overnight. It was then 
dissolved in dry CH2Cl2 (2 mL) and dry MeCN (2 mL), cooled to  
-30 °C, followed by addition of NIS (51 mg; 0.31 mmol) and 
TESOTf (9 mg; 0.04 mmol). The reaction mixture was stirred at  
-30 °C until TLC revealed full conversion of the donor (1 h). The 
solution was diluted with CH2Cl2 (50 mL) and washed with sat. aq. 
NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The organic phase 
was dried over MgSO4, filtered and concentrated. The product was 
purified by flash chromatography (19:1 Tol/EtOAc) to afford a 
white solid. Yield: 245 mg (72%). IR (neat,cm-1):3524.96, 
2972.52, 2933.68, 2906.86, 2872.57, 1734.93, 1496.69, 1456.03, 
1397.62, 1366.61, 1277.07, 1170.07, 1082.44, 1046.46, 1001.32. 
1H NMR (400 MHz, CDCl3) δ 8.11 – 7.81 (m, 6H, Ar-HBz), 7.58 – 
6.99 (m, 49H, Ar-H), 5.53 (s, 1H, CHbenzylidene), 5.49 (s, 1H, CHben-
zylidene), 5.47 (s, 1H, CHbenzylidene), 5.47 (s, 1H, CHbenzylidene), 5.45 (s, 
1H, CHbenzylidene), 5.44 (s, 1H, CHbenzylidene), 5.43 – 5.42 (m, 1H, H-
2’/H-3’,), 5.40 – 5.25 (m, 8H, H-2’/H-3’, H-21-H-27), 5.14 (s, 1H, 
H-1’), 4.83 (d, J1,2 = 8.1 Hz, 1H, H-1), 4.79 (d, JCH2 = 11.9 Hz, 1H, 
0.5xCH2Bn), 4.75 – 4.59 (m, 8H, 5xH-1, H-37, H-5a’, 0.5xCH2Bn), 
4.50 (dd, J5a,5b = 12.3, J4,5b = 4.6 Hz, 1H, H-5b’), 4.43 (d, JCH2 = 
11.9 Hz, 1H, 0.5xCH2Bn), 4.34 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.33 – 
3.90 (m, 26H, H-31-H-36, 6xH-41/2/3/4/6/7, 6xH-61/2/3/4/6/7, H-4’, 
0.5xCH2Bn), 3.84 (d, J3,4 = 2.9 Hz, 1H, H-45), 3.76 (dd, J6a,6b = 9.5, 
J5,6a = 6.0 Hz, 1H, H-6a5), 3.55 (t, J5,6a = J5,6b = 6.0 Hz, 1H, H-55), 
3.48 (dd, J6a,6b = 9.5, J5,6b = 6.0 Hz, 1H, H-6b5), 3.43 (s, 1H, H-
51/2/3/4/6/7), 3.37 (s, 1H, H-51/2/3/4/6/7), 3.30 (s, 1H, H-51/2/3/4/6/7), 3.26 
(s, 1H, H-51/2/3/4/6/7), 3.23 (s, 1H, H-51/2/3/4/6/7), 3.22 (s, 1H, H-
51/2/3/4/6/7), 1.07 (s, 9H, 3xCH3Piv), 1.07 (s, 9H, 3xCH3Piv), 1.06 (s, 
9H, 3xCH3Piv), 1.05 (s, 18H, 6xCH3Piv), 1.00 (s, 9H, 3xCH3Piv), 0.99 
(s, 9H, 3xCH3Piv), 0.99 (s, 9H, 3xCH3Piv). 13C NMR (101 MHz, 
CDCl3) δ 178.3, 176.9, 176.20, 176.18, 176.02, 175.98, 175.97, 
175.8, 166.3, 166.24, 166.22, 138.7, 138.03, 137.96, 137.92, 
137.86, 137.8, 137.6, 137.3, 133.8, 133.7, 133.3, 130.2-125.4 
(55C), 106.5, 101.1, 100.6, 100.5, 100.4, 100.34, 100.29 (2C), 
100.2 (2C), 100.1, 100.0, 99.8, 99.3, 82.6, 82.1, 81.5, 81.4, 78.1, 
77.6, 77.4, 76.9, 76.03, 75.95, 75.91, 75.7, 74.54, 74.46, 74.2, 73.2, 
72.3, 72.0, 71.9, 71.74, 71.69, 71.6, 71.5, 71.4, 71.3, 71.1, 70.0, 
68.9, 68.6, 68.4, 67.8, 67.7, 67.5, 67.3, 67.1, 66.9, 64.0, 63.8, 63.6, 
39.0, 38.8, 38.73 (5C), 38.68, 27.4 (3C), 27.3 (6C), 27.3 (6C), 
27.20 (3C), 27.16 (3C), 27.1 (3C).  
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-[4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galacto-
pyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopy-
ranosyl-(1→6)]-4-O-benzyl-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
noside (40). To a 25 mL flame-dried flask was added 33 (500 mg, 
0.20 mmol) and the 35 (281 mg, 0.30 mmol). The mixture was 
dried azeotropically with toluene (2x5 mL) and subjected to vac-
uum overnight. It was then dissolved in dry CH2Cl2 (2 mL) and dry 
MeCN (2 mL), cooled to -30 °C, followed by addition of NIS 
(69 mg; 0.31 mmol) and TESOTf (10 mg; 0.04 mmol). The reac-
tion mixture was stirred at -30 °C until TLC revealed full conver-
sion of the donor (1 h). The solution was diluted with CH2Cl2 
(50 mL) and washed with sat. aq. NaS2O3 (50 mL) and sat. aq.  
NaHCO3 (50 mL). The organic phase was dried over MgSO4, fil-
tered and concentrated. The product was purified by flash chroma-
tography (19:1 Tol/EtOAc) to afford a white solid. Yield: 505 mg 
(76%). IR (neat, cm-1): 3524.96, 2972.52, 2933.68, 2906.86, 
2872.57, 1734.93, 1496.69, 1456.03, 1397.62, 1366.61 1277.07, 
1170.07, 1082.44, 1046.46, 1001.32. 1H NMR (400 MHz, CDCl3) 
δ 7.41 (m, 14H, Ar-H), 7.33 – 7.03 (m, 38H, Ar-H), 5.53 – 5.11 (m, 
16H, 7xCHbenzylidene, H-21-H-27, H-21’, H-22’), 4.94 (dd, J2,3 = 10.4, 
J3,4 = 3.1 Hz, 1H, H-37/1’/2’), 4.84 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.89 – 
4.74 (m, 3H, , H-37/1’/2’, CH2Bn), 4.73 – 4.60 (m, 5H, 3xH-1, H-
37/1’/2’, 0.5xCH2Bn), 4.59 (d, J1,2 = 8.1 Hz, 1H, H-1), 4.55 (d, JCH2 = 
11.2 Hz, 1H, 0.5xCH2Bn), 4.47 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.45 (d, 
JCH2 = 11.9 Hz, 1H, 0.5xCH2Bn), 4.41 (d, JCH2 = 12.2 Hz, 1H, 
0.5xCH2Bn), 4.36 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.32 (d, J = 3.8 Hz, 
1H, H-41/2/3/4/6/7/2’), 4.28 (d, J = 4.0 Hz, 1H, H-41/2/3/4/6/7/2’), 4.25 – 
3.87 (m, 30H, H-31-H-36, H-41/2/3/4/6/7/2’, H-41/2/3/4/6/7/2’, H-
41/2/3/4/6/7/2’, H-41/2/3/4/6/7/2’, H-41/2/3/4/6/7/2’, H-41/2/3/4/6/7/2’, H-61-H-67, 
H-61’, H-62’), 3.79 (d, J3,4 = 3.4 Hz, 1H, H-45/1’), 3.74 (d, J3,4 = 3.8 
Hz, 1H, H-45/1’), 3.52 (dd, J5,6a = 9.6, J5,6b = 6.4 Hz, 1H, H-55/1’), 
3.48 (dd, J5,6a = 7.9, J5,6b = 5.6 Hz, 1H, H-55/1’), 3.39 (s, 1H, H-
 51/2/3/4/6/7/2’), 3.35 (s, 1H, H-51/2/3/4/6/7/2’), 3.33 (s, 1H, H-51/2/3/4/6/7/2’), 
3.31 (s, 1H, H-51/2/3/4/6/7/2’), 3.29 (s, 1H, H-51/2/3/4/6/7/2’), 3.26 (s, 1H, 
H-51/2/3/4/6/7/2’), 3.20 (s, 1H, H-51/2/3/4/6/7/2’), 1.08 (s, 9H, 3xCH3Piv), 
1.08 (s, 9H, 3xCH3Piv), 1.075 (s, 18H, 3xCH3Piv), 1.07 (s, 9H, 
3xCH3Piv), 1.04 (s, 18H, 3xCH3Piv), 1.02 (s, 9H, 3xCH3Piv), 1.02 (s, 
9H, 3xCH3Piv), 0.99 (s, 9H, 3xCH3Piv), 0.98 (s, 9H, 3xCH3Piv), 0.98 
(s, 9H, 3xCH3Piv). 13C NMR (101 MHz, CDCl3) δ 178.2, 178.1, 
177.5, 176.8, 176.4, 176.3, 176.2, 176.1, 176.0, 175.89, 175.87, 
175.8, 139.1, 138.1, 137.9, 137.9, 137.9, 137.82, 137.77, 137.6, 
137.5, 137.2, 129.4-125.9 (38C), 101.7, 100.8, 100.5 (2C), 100.4, 
100.34, 100.28, 100.2, 100.2 (2C), 100.13, 100.07, 100.0, 99.7, 
99.6, 99.1, 77.3, 75.9, 75.93, 75.87, 75.70, 75.66, 75.3, 74.5, 74.31, 
74.25, 73.2, 73.1, 72.3, 71.9, 71.8, 71.7, 71.5, 71.3, 71.2, 71.1, 70.9, 
70.0, 69.8, 68.8, 68.7, 68.6, 68.5, 68.3, 68.2, 67.4, 67.3, 66.9, 66.8, 
66.4, 66.3, 38.91, 38.91, 38.87, 38.74, 38.71, 38.67 (2C), 38.63, 
38.61, 38.59, 38.58, 38.5, 27.29 (6C), 27.25 (3C), 27.23 (3C), 27.21 
(3C), 27.19 (3C), 27.16 (3C), 27.14 (3C), 27.11 (3C), 27.0 (6C), 
27.0 (3C). 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-[4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galacto-
pyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galacto-
pyranosyl-(1→6)]-4-O-benzyl-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
noside (37). To a 25 mL flame-dried flask was added 27 (600 mg, 
0.24 mmol) and the 20 (306 mg, 0.36 mmol). The mixture was 
dried azeotropically with toluene (2x5 mL) and subjected to vac-
uum overnight. It was then dissolved in dry CH2Cl2 (2 mL) and dry 
MeCN (2 mL), cooled to -30 °C, followed by addition of NIS 
(82 mg; 0.37 mmol) and TESOTf (13 mg; 0.05 mmol). The reac-
tion mixture was stirred at -30 °C until TLC revealed full conver-
sion of the donor (2 h). The solution was diluted with CH2Cl2 
(50 mL) and washed with sat. aq. NaS2O3 (50 mL) and sat. aq. Na-
HCO3 (50 mL). The organic phase was dried over MgSO4, filtered 
and concentrated. The product was purified by flash chromatog-
raphy (19:1 Tol/EtOAc) to afford a white solid. Yield: 575 mg 
(74%). IR (neat, cm-1): 3535.58, 2972.41, 2872.16, 1736.19, 
1700.99, 1479.69, 1455.60, 1397.63, 1366.51, 1276.86, 1171.43, 
1132.66, 1084.76, 1046.59, 999.84. 1H NMR (400 MHz, CDCl3) δ 
7.43 (m, 16H, Ar-H), 7.34 – 7.14 (m, 34H, Ar-H), 5.49 (s, 1H, 
CHbenzylidene), 5.48 – 5.46 (m, 2H, 2xCHbenzylidene), 5.45 (s, 2H, 
2xCHbenzylidene), 5.44 (s, 2H, 2xCHbenzylidene), 5.42 (s, 1H, CHbenzyli-
dene), 5.40 – 5.25 (m, 7H, 7xH-2), 5.21 (dd, J2,3 = 10.3, J1,2 = 7.9 Hz, 
1H, H-2), 5.13 (dd, J2,3 = 10.3, J1,2 = 8.0 Hz, 1H, H-2), 4.85 – 4.76 
(m, 4H, 2xH-1, CH2Bn), 4.74 – 4.62 (m, 5H, 3xH-1, H-37, H-32’), 
4.55 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.50 (d, JCH2 = 12.5 Hz, 1H, 
0.5xCH2Bn), 4.49 (d, J1,2 = 7.6 Hz, 1H, H-1), 4.44 (d, JCH2 = 12.0 
Hz, 1H, 0.5xCH2Bn), 4.34 (d, J = 8.0 Hz, 1H, H-1), 4.33 – 3.91 (m, 
29H, H-31-H-36, H-31’, 8xH-41/2/4/5/6/7/1’/2’, 7.5xH-61/2/4/5/6/7/1’/2’), 
3.89 (d, J1,2 = 7.8 Hz, 1H, H-11’), 3.84 (d, J6a,6b = 11.9 Hz, 1H, H-
61/2/4/5/6/7/1’/2’), 3.74 (d, J3,4 = 3.4 Hz, 1H, H-43), 3.64 – 3.52 (m, 1H, 
H-63), 3.47 (t, J5,6a = J5,6b = 5.6 Hz, 1H, H-53), 3.38 (s, 1H, H-
51/2/4/5/6/7/1’/2’), 3.35 (s, 1H, H-51/2/4/5/6/7/1’/2’), 3.30 (s, 1H, H-
51/2/4/5/6/7/1’/2’), 3.27 (s, 1H, H-51/2/4/5/6/7/1’/2’), 3.22 (s, 1H, H-
51/2/4/5/6/7/1’/2’), 3.20 (s, 2H, 2xH-51/2/4/5/6/7/1’/2’), 3.04 (s, 1H, H-
51/2/4/5/6/7/1’/2’), 1.13 (s, 9H, 3xCH3Piv), 1.08 (s, 9H, 3xCH3Piv), 1.06 
(s, 9H, 3xCH3Piv), 1.04 (s, 9H, 3xCH3Piv), 1.03 (s, 18H, 6xCH3Piv), 
1.01 (s, 9H, 3xCH3Piv), 1.00 (s, 9H, 3xCH3Piv), 1.00 (s, 9H, 
3xCH3Piv), 0.99 (s, 9H, 3xCH3Piv), 0.97 (s, 9H, 3xCH3Piv). 13C NMR 
(101 MHz, CDCl3) δ 178.32, 178.26, 176.9, 176.8, 176.5, 176.2, 
176.2, 176.1, 176.0 (2C), 175.7, 138.9, 138.2, 138.03, 138.00, 
137.98, 137.9, 137.8, 137.6 (2C), 137.4, 129.2-125.4 (50C), 102.6, 
100.7, 100.6, 100.5, 100.4, 100.3 (4C), 100.2 (3C), 100.0, 99.9, 
99.7, 99.6, 99.3, 77.4, 76.0, 75.9, 75.8, 75.7, 75.5, 75.2, 74.8, 74.4, 
74.2, 73.23, 73.15, 73.0, 72.6, 72.3, 72.1, 72.0, 71.9, 71.7, 71.6, 
71.5, 71.4, 71.3, 71.1, 69.9, 69.2, 69.0, 68.93, 68.88, 68.8, 68.6, 
68.4, 68.0, 67.6, 67.5, 67.3, 67.0, 66.9, 66.9, 66.8, 66.7, 65.2, 39.1, 
39.03, 39.01, 38.83, 38.80, 38.79, 38.77, 38.71 (3C), 38.68, 38.67, 
27.5 (3C), 27.4 (6C), 27.29 (3C), 27.27 (3C), 27.25 (3C), 27.20 
(3C), 27.15 (6C), 27.12 (3C), 27.10 (3C). 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-[4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galacto-
pyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galacto-
pyranosyl-(1→6)]-4-O-benzyl-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-Obenzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
nosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyra-
noside (39). To a 25 mL flame-dried flask was added 33 (500 mg, 
0.20 mmol) and the 20 (255 mg, 0.30 mmol). The mixture was 
dried azeotropically with tol-uene (2x5 mL) and subject-ted to  
vacuum overnight. It was then dissolved in dry CH2Cl2 (2 mL) and 
dry MeCN (2 mL), cooled to -30 °C, followed by addition of NIS 
(69 mg; 0.31 mmol) and TESOTf (10 mg; 0.04 mmol). The reac-
tion mixture was stirred at -30 °C until TLC revealed full conver-
sion of the donor (1 h). The solution was diluted with CH2Cl2 
(50 mL) and washed with sat. aq. NaS2O3 (50 mL) and sat. aq.  
NaHCO3 (50 mL). The organic phase was dried over MgSO4, fil-
tered and concentrated. The product was purified by flash chroma-
tography (19:1 Tol/EtOAc) to afford a white solid. Yield: 460 mg 
(71%). IR (neat, cm-1): 2973.10, 2933.38, 2906.81, 2872.23, 
1736.16, 1701.44, 1479.68, 1455.34, 1397.62, 1366.36, 1276.86, 
1171.55, 1132.07, 1085.98, 1046.35, 1026.49, 999.26. 1H NMR 
(400 MHz, CDCl3) δ 7.42 (m, 16H, Ar-H), 7.23 (m, 34H, Ar-H), 
5.57 – 5.07 (m, 17H, H-21, H-27-H-21’, H-22’, 8xCHbenzylidene), 4.88 
– 4.81 (m, 3H, 2xH-1, 0.5xCH2Bn), 4.79 (d, JCH2 = 11.5 Hz, 1H, 
0.5xCH2Bn), 4.74 – 4.66 (m, 3H, H-37/2’, H-37/2’, H-1), 4.65 (d, J1,2 
= 7.9 Hz, 1H, H-1), 4.61 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.55 (d, J1,2 = 
7.9 Hz, 1H, H-1), 4.53 (d, JCH2 = 11.7 Hz, 1H, 0.5xCH2Bn), 4.47 (d, 
J1,2 = 7.9 Hz, 1H, H-1), 4.45 (d, JCH2 = 11.6 Hz, 1H, CH2Bn), 4.36 
(d, J1,2 = 7.9 Hz, 1H, H-1), 4.33 – 3.84 (m, 31H, H-31-H-36, H-31’, 
8xH-41/2/3/4/6/7/1’/2’, 8xH-61/2/3/4/6/7/1’/2’), 3.89 (d, J1,2 = 7.8 Hz, 1H, H-
11’), 3.82 (m, 1H, H-6a5), 3.78 (t, J3,4 = 3.4 Hz, 1H, H-45), 3.69 – 
3.53 (m, 1H, H-6b5), 3.47 (d, J5,6a = J5,6b = 5.3 Hz, 1H, H-55), 3.38 
– 3.35 (m, 2H, 2xH-51/2/3/4/6/7/1’/2’), 3.30 (s, 1H, H-51/2/3/4/6/7/1’/2’), 
3.24 (s, 1H, H-51/2/3/4/6/7/1’/2’), 3.23 (s, 1H, H-51/2/3/4/6/7/1’/2’), 3.21 (s, 
1H, H-51/2/3/4/6/7/1’/2’), 3.17 (s, 1H, H-51/2/3/4/6/7/1’/2’), 3.00 (s, 
1H, H-51/2/3/4/6/7/1’/2’), 1.11 (s, 9H, 3xCH3Piv), 1.08 (s, 9H, 3xCH3Piv), 
1.07 (s, 27H, 9xCH3Piv), 1.04 (s, 9H, 3xCH3Piv), 1.02 (s, 9H, 
3xCH3Piv), 1.00 (s, 9H, 3xCH3Piv), 0.98 (s, 9H, 3xCH3Piv), 0.98 (s, 
9H, 3xCH3Piv), 0.95 (s, 9H, 3xCH3Piv). 13C NMR (101 MHz, 
CDCl3) δ 178.3, 178.2 177.0, 176.9, 176.34, 176.31, 176.10, 
176.07, 176.01, 175.97, 175.7, 138.9, 138.1, 138.03, 137.98 (2C), 
137.9, 137.7, 137.6 (2C), 137.3, 129.1-125.4 (34C), 102.4, 100.7, 
100.5 (2C), 100.4, 100.3, 100.3 (3C), 100.2, 100.1 (2C), 99.8, 99.7, 
99.6, 99.5, 99.2, 77.4, 76.0, 75.91, 75.85, 75.7, 75.3, 75.2, 74.7, 
74.4, 74.2, 73.23, 73.15, 73.0, 72.5, 72.4, 72.03, 71.99, 71.9, 71.5, 
71.2, 71.1, 71.0, 70.1, 69.2, 68.9, 68.8, 68.6, 68.4, 68.3, 68.0, 67.6, 
67.5, 67.4, 67.0, 66.91, 66.87, 66.8, 66.7, 39.02, 39.00, 38.79 (2C), 
38.77 (3C), 38.71, 38.69, 38.66, 38.6, 27.40 (6C), 27.36 (3C), 27.30 
(3C), 27.29 (3C), 27.22 (3C), 27.21 (3C), 27.15 (3C), 27.12 (6C), 
27.09 (3C). 
β-D-Galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-
D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-D-ga-
lactopyranose (1). 24 (350 mg; 0.18 mmol) was dissolved in 
THF (40 mL) and a 1 M Et4NOH in MeOH solution (7.4 mL; 7.4 
mmol) was added. The reaction mixture was stirred at 65 ˚C for 
 24 h. The reaction mixture was poured into sat. aq. NH4Cl (100 
mL) and extracted with CH2Cl2 (3x100 mL). The combined or-
ganic phases were dried over MgSO4, filtered and concentrated. 
The product was purified by flash chromatography (9:1 
CH2Cl2/MeOH) to yield colorless crystals. The product was dis-
solved in MeOH (40 mL), THF (10 mL). 20% Pd(OH)2/C (129 
mg; 0.18 mmol) was added and an atmosphere of H2 (1 atm.) was 
installed. The reaction was stirred at 22 ˚C for 48 h, filtered 
through celite, and concentrated to give a grey solid. Purified by 
reverse phase chromatography to afford 1 as a white solid. Yield: 
119 mg (78% over two steps). 1H NMR (800 MHz, D2O) δ 5.19 
(d, J3,4 = 3.1 Hz, 1H, H-1α), 4.62 – 4.49 (m, 9H, H-11β, H-15β, H-
12α, H-15α), 4.17 (d, J3,4 = 3.4 Hz, 1H, H-4), 4.11 (m, 9H, 9xH-
4), 4.03 (t, J = 6.3 Hz, 1H), 3.90 (t, J = 3.0 Hz, 1H), 3.83 (d, J = 
3.3 Hz, 3H), 3.80 – 3.47 (m, 45H). 13C NMR (201 MHz, D2O) δ 
104.4, 104.2, 104.2, 104.1, 96.3, 92.3, 82.6, 82.1, 82.1, 79.5, 75.2, 
74.9, 74.8, 74.7, 72.6, 71.1, 71.0, 70.4, 70.3, 70.2, 69.3, 68.7, 
68.7, 68.5, 68.4, 67.5, 61.2, 61.1, 61.0, 61.0. HRMS (MALDI) 
m/z: [M + H]+ Calcd for C30H53O26 829.2820 Found 829.2841. 
 
β-D-Galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-
D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-D-
galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-D-galac-
topyranose (2). 26 (325 mg; 0.13 mmol) was dissolved in THF 
(40 mL) and a 1 M Et4NOH in MeOH solution (7.6 mL; 7.6 
mmol) was added. The reaction mixture was stirred at 65 ˚C for 
24 h. The reaction mixture was poured into sat. aq. NH4Cl (100 
mL) and extracted with CH2Cl2 (3x100 mL). The combined or-
ganic phases were dried over MgSO4, filtered and concentrated. 
The product was purified by flash chromatography (9:1 
CH2Cl2/MeOH) to yield colorless crystals. The product was dis-
solved in MeOH (40 mL), THF (10 mL). 20% Pd(OH)2/C (88 mg; 
0.13 mmol) was added and an atmosphere of H2 (1 atm.) was in-
stalled. The reaction was stirred at 22 ˚C for 48 h, filtered through 
celite, and concentrated to give a grey solid. Purified by reverse 
phase chromatography to afford 2 as a white solid. Yield: 107 mg 
(74% over two steps). 1H NMR (800 MHz, D2O) δ 5.19 (d, J1,2 = 
3.0 Hz, 1H, H-1α), 4.63 – 4.48 (m, 13H, H-11β, H-17β, H-12α, H-
17α), 4.16 (d, J3,4 = 3.2 Hz, 1H), 4.11 (m, 13H), 4.03 (t, J = 6.3 
Hz, 1H), 3.90 (t, J = 3.0 Hz, 2H), 3.83 (d, J = 3.2 Hz, 2H), 3.80 – 
3.47 (m, 65H). 13C NMR (201 MHz, D2O) δ 104.4, 104.2, 104.1, 
104.1, 96.3, 92.3, 82.5, 82.1, 82.1, 81.8, 79.5, 75.2, 74.9, 74.8, 
74.7, 72.6, 71.1, 71.0, 70.4, 70.3, 70.2, 69.3, 68.7, 68.5, 68.4, 
67.5, 61.2, 61.1, 61.0. HRMS (ESI) m/z: [M + Na]+ Calcd for 
C42H72O36 1175.3695 Found 1175.3685. 
 
β-D-Galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-
D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-[β-D-
galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→6)]-β-D-ga-
lactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-D-galacto-
pyranose (3). 37 (380 mg; 0.12 mmol) was dissolved in THF (30 
mL) and a 1 M Et4NOH in MeOH solution (9.24 mL; 9.24 mmol) 
was added. The reaction mixture was stirred at 65 ˚C for 24 h. The 
reaction mixture was poured into sat. aq. NH4Cl (100 mL) and ex-
tracted with CH2Cl2 (3x100 mL). The combined organic phases 
were dried over MgSO4, filtered and concentrated. The product was 
purified by flash chromatography (9:1 CH2Cl2/MeOH) to yield col-
orless crystals. The product was dissolved in MeOH (40 mL), THF 
(10 mL). 20% Pd(OH)2/C (84 mg; 0.12 mmol) was added and an 
atmosphere of H2 (1 atm.) was installed. The reaction was stirred at 
22 ˚C for 48 h, filtered through celite, and concentrated to give a 
grey solid. Purified by reverse phase chromatography to afford 3 as 
a white solid. Yield: 112 mg (66% over two steps). 1H NMR 
(800 MHz, D2O) δ 5.29 (d, J1,2 = 3.1 Hz, 1H, H-1α), 4.73 – 4.58 
(m, 15H, H-11β, H-17β, H-12α, H-17α, H-1'6branchα, H-1'6branchβ), 
4.49 (d, J1,2 = 7.8 Hz, 2H, H-16branchα, H-16branchβ), 4.26 (d, J3,4 = 
3.3 Hz, 1H, H-41α), 4.22 (m, 17H, 17xH-4), 4.12 (t, J = 6.3 Hz, 
1H), 4.08 – 3.55 (m, 89H). 13C NMR (201 MHz, D2O) δ 104.5, 
104.4, 104.2, 104.1, 104.0, 103.9, 103.2, 96.2, 92.2, 82.65, 82.6, 
82.5, 82.1, 82.05, 82.0, 81.95, 81.9, 81.8, 79.6, 75.1, 74.8, 74.8, 
74.8, 73.4, 72.6, 71.1, 71.1, 71.0, 70.3, 70.2, 70.2, 69.9, 69.3, 69.2, 
68.6, 68.5, 68.4, 68.4, 68.4, 67.4, 61.2, 61.0, 60.9. HRMS 
(MALDI) m/z: [M + Na]+ Calcd for C54H92O46Na 1499.4752 
Found 1499.4780. 
β-D-Galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-[β-
D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→6)]-β-D-
galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-D-ga-
lactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-D-galacto-
pyranose (4). 39 (318 mg; 0.097 mmol) was dissolved in THF 
(30 mL) and a 1 M Et4NOH in MeOH solution (7.7 mL; 7.7 mmol) 
was added. The reaction mixture was stirred at 65 ˚C for 24 h. The 
reaction mixture was poured into sat. aq. NH4Cl (100 mL) and ex-
tracted with CH2Cl2 (3x100 mL). The combined organic phases 
were dried over MgSO4, filtered and concentrated. The product 
was purified by flash chromatography (9:1 CH2Cl2/MeOH) to yield 
colorless crystals. The product was dissolved in MeOH (40 mL), 
THF (10 mL). 20% Pd(OH)2/C (68 mg; 0.097 mmol) was added 
and an atmosphere of H2 (1 atm.) was installed. The reaction was 
stirred at 22 ˚C for 48 h, filtered through celite, and concentrated to 
give a grey solid. Purified by reverse phase chromatography to af-
ford 4 as a white solid. Yield: 102 mg (72% over two steps). 1H 
NMR (800 MHz, D2O) δ 5.28 (d, J1,2 = 3.0 Hz, 1H, H-1α), 4.73 – 
4.58 (m, 15H, H-11β, H-17β, H-12α, H-17α, H-1'branchα, H-1'branchβ), 
4.49 (d, J1,2 = 7.9 Hz, 3H, H-1branchα, H-1branchβ), 4.26 (d, J3,4 = 3.1 
Hz, 1H, H-4α), 4.22 (m, 17H, 17xH-4), 4.12 (t, J = 6.2 Hz, 1H), 
4.09 – 3.56 (m, 89H). 13C NMR (201 MHz, D2O) δ 104.5, 104.4, 
104.1, 104.1, 104.0, 103.9, 103.2, 96.2, 92.2, 82.6, 82.5, 82.1, 82.0, 
82.0, 81.9, 79.4, 75.1, 74.8, 74.8, 74.7, 74.7, 73.4, 72.6, 71.1, 71.1, 
71.0, 70.3, 70.3, 70.2, 70.2, 70.2, 69.9, 69.3, 69.2, 68.6, 68.5, 68.4, 
68.4, 67.4, 61.2, 61.0, 60.9. HRMS (MALDI) m/z: [M + H]+ Calcd 
for C54H93O46 1477.4933 Found 1477.4953. 
β-D-Galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-[β-
D-galactopyranosyl-(1→6)-β-D-galactopyranosyl-(1→6)]-β-D-
galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-D-ga-
lactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-D-galacto-
pyranose (5). 40 (328 mg; 0.097 mmol) was dissolved in THF 
(30 mL) and a 1 M Et4NOH in MeOH solution (7.78 mL; 
7.78 mmol) was added. The reaction mixture was stirred at 65 ˚C 
for 24 h. The reaction mixture was poured into sat. aq. NH4Cl 
(100 mL) and extracted with CH2Cl2 (3x100 mL). The combined 
organic phases were dried over MgSO4, filtered and concentrated. 
The product was purified by flash chromatography (9:1 
CH2Cl2/MeOH) to yield a colorless foam. The product was dis-
solved in MeOH (30 mL), THF (7.5 mL). 20% Pd(OH)2/C (68 mg; 
0.097 mmol) was added and an atmosphere of H2 (1 atm.) was in-
stalled. The reaction was stirred at 22 ˚C for 48h, filtered through 
celite, and concentrated to give a grey solid. Purified by reverse 
phase chromatography to afford 5 as a white solid. Yield: 99 mg 
(69% over two steps). 1H NMR (800 MHz, D2O) δ 5.19 (d, J1,2 = 
3.1 Hz, 1H, H-1α), 4.64 – 4.48 (m, 13H, H-11β, H-17β, H-12α, H-
17α), 4.36 (d, J1,2 = 7.8 Hz, 2H, H-16branchα, H-16branchβ), 4.35 (d, 
J1,2 = 7.8 Hz, 2H, H-1'6branchα, H-1'6branchβ), 4.19 – 4.08 (m, 18H, 
18xH-4), 4.03 (t, J = 6.3 Hz, 1H), 3.98 – 3.38 (m, 89H). 13C NMR 
(201 MHz, D2O) δ 104.4, 104.2, 104.1, 104.1, 104.1, 103.9, 103.6, 
103.5, 96.2, 92.2, 82.5, 82.1, 82.0, 82.0, 81.8, 79.5, 75.2, 75.1, 74.9, 
74.8, 74.8, 74.7, 73.8, 73.3, 72.8, 72.7, 72.6, 71.1, 71.0, 70.8, 70.8, 
70.3, 70.3, 70.3, 70.2, 69.5, 69.4, 69.2, 68.7, 68.6, 68.5, 68.4, 67.5, 
61.2, 61.1, 61.0, 61.00, 61.0. HRMS (MALDI) m/z: [M + H]+ 
Calcd for C54H93O46 1477.4933 Found 1477.4956. 
 β-D-Galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-[α-
L-arabinosyl-(1→6)]-β-D-galactopyranosyl-(1→3)-β-D-galacto-
pyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-D-galactopy-
ranosyl-(1→3)-D-galactopyranose (6). 38 (300 mg; 0.10 mmol) 
was dissolved in THF (30 mL) and a 1 M Et4NOH in MeOH solu-
tion (8.1 mL; 8.1 mmol) was added. The reaction mixture was 
stirred at 65 ˚C for 24 h. The reaction mixture was poured into sat. 
aq. NH4Cl (100 mL) and extracted with CH2Cl2 (3x100 mL). The 
combined organic phases were dried over MgSO4, filtered and con-
centrated. The product was purified by flash chromatography (9:1 
CH2Cl2/MeOH) to yield colorless crystals. The product was dis-
solved in MeOH (40 mL), THF (10 mL). 20% Pd(OH)2/C (70 mg; 
0.097 mmol) was added and an atmosphere of H2 (1 atm.) was in-
stalled. The reaction was stirred at 22 ˚C for 48 h, filtered through 
celite, and concentrated to give a grey solid. Purified by reverse 
phase chromatography to afford 6 as a white solid. Yield: 84 mg 
(65% over two steps). 1H NMR (800 MHz, D2O) δ 5.29 (d, J1,2 = 
3.0 Hz, 1H, H-1α), 5.08 – 5.04 (m, 2H, H-1araα, H-1araβ), 4.74 – 
4.57 (m, 13H, H-11β, H-17β, H-12α, H-17α), 4.26 (d, J3,4 = 3.1 Hz, 
1H, H-4α), 4.21 (m, 13H, 13xH-4), 4.12 (t, J = 6.2 Hz, 1H), 4.10 – 
3.36 (m, 79H). 13C NMR (201 MHz, D2O) δ 108.0, 104.4, 104.2, 
104.1, 104.1, 104.1, 103.9, 96.3, 92.3, 84.0, 82.5, 82.2, 82.1, 82.1, 
82.0, 81.2, 79.5, 76.6, 75.2, 74.9, 74.8, 73.5, 72.6, 71.1, 71.0, 70.3, 
70.2, 69.3, 68.7, 68.6, 68.6, 68.5, 68.4, 67.5, 67.5, 61.3, 61.2, 61.1, 
61.0. HRMS (MALDI) m/z: [M + 2Na]+ Calcd for C47H80O40Na2 
665.2005 Found 665.2018. 
β-D-Galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-
D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-[α-L-
arabinosyl-(1→6)]-β-D-galactopyranosyl-(1→3)-β-D-galacto-
pyranosyl-(1→3)-D-galactopyranose (7). 36 (320 mg; 
0.11 mmol) was dissolved in THF (30 mL) and a 1 M Et4NOH in 
MeOH solution (9.24 mL; 9.24 mmol) was added. The reaction 
mixture was stirred at 65 ˚C for 24 h. The reaction mixture was 
poured into sat. aq. NH4Cl (100 mL) and extracted with CH2Cl2 
(3x100 mL). The combined organic phases were dried over 
MgSO4, filtered and concentrated. The product was purified by 
flash chromatography (9:1 CH2Cl2/MeOH) to yield a colorless 
foam. The product was dissolved in MeOH (30 mL), THF (7.5 mL). 
20% Pd(OH)2/C (75 mg; 0.11 mmol) was added and an atmosphere 
of H2 (1 atm.) was installed. The reaction was stirred at 22 ˚C for 
48 h, filtered through celite, and concentrated to give a grey solid. 
Purified by reverse phase chromatography to afford 7 as a white 
solid. Yield: 82 mg (60% over two steps). 1H NMR (800 MHz, 
D2O) δ 5.19 (d, J1,2 = 3.1 Hz, 1H, H-1α), 4.97 (m, 2H, H-1araα, H-
1araβ), 4.63 – 4.51 (m, 11H, H-11β, H-17β, H-12α, H-17α), 4.16 (d, 
J3,4 = 3.5 Hz, 1H, H-4α),4.13 – 4.08 (m, 13H, 13xH-4), 4.03 (t, J = 
6.2 Hz, 1H), 4.00 – 3.92 (m, 4H), 3.90 (t, J = 2.9 Hz, 2H), 3.88 – 
3.46 (m, 69H). 13C NMR (201 MHz, D2O) δ 108.0, 104.4, 104.2, 
104.2, 104.1, 103.9, 96.3, 92.3, 84.0, 82.6, 82.2, 82.1, 82.1, 82.0, 
81.2, 79.5, 76.6, 75.2, 74.9, 74.8, 74.8, 74.8, 73.5, 72.6, 71.1, 71.1, 
70.4, 70.3, 70.3, 70.2, 69.3, 68.7, 68.6, 68.6, 68.5, 68.4, 67.5, 67.5, 
61.3, 61.2, 61.1, 61.1, 61.0, 61.0. HRMS (MALDI) m/z: [M + H]+ 
Calcd for C47H81O40 1285.4299 Found 1285.4321. 
Glycan microarray printing and analysis of JIM16 and JIM133 
binding  
The oligosaccharides were diluted in coupling buffer (80% 50 mM 
sodium phosphate, pH 8.5, 0.005% CHAPS, 20% PEG400 (Roth)) 
to four concentrations (200 μM, 50 μM, 12.5 µM, and 3.1 µM), and 
printed on CodeLink N-hydroxyl succinimide (NHS) ester-acti-
vated glass slides (SurModics Inc., Eden Prairie, MN, USA) using 
a non-contact piezoelectric spotting device (S3; Scienion, Berlin, 
Germany). After printing, the microarray slides were quenched for 
1 h at room temperature in quenching buffer (100 mM ethanola-
mine, 50 mM sodium phosphate, pH 9) and washed three times 
with deionized water. The monoclonal antibodies JIM16 and 
JIM133 were obtained from Plant Probes (Leeds, UK) and the 
Complex Carbohydrate Research Center (CCRC, Athens, Georgia, 
USA), respectively. We applied a FlexWell 64 grid (Grace Bio-
Labs, Bend, OR, USA) to the slide and blocked the slides with 1% 
bovine serum albumin (BSA) in phosphate-buffered saline (PBS) 
for 1 h at room temperature. Then, JIM16 and JIM133 hybridoma 
supernatant was diluted 1:10 in PBS containing 1% BSA and incu-
bated for 1 h on the slides. After three washes with PBS, the slides 
were incubated with the secondary goat anti-rat IgG AF555 anti-
body (Invitrogen, Carlsbad, CA, USA) for 1 h. After consecutive 
washes with 0.1% Tween-20 in PBS, PBS, and deionized water, the 
slides were dried by centrifugation (300 x g, 2 min), and the fluo-
rescent signal on the slides was scanned with a GenePix 4300A mi-
croarray scanner (Molecular Devices, Sunnyvale, CA, USA) as 
shown in Figure 3. To obtain the percentages of maximal binding 
as shown in Table 1, the fluorescent signal of the 200 µM concen-
tration was quantified using the GenePix Pro 7 software (Molecular 
Devices) and normalized to the highest value (given the value 100).  
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